<?xml version="1.0"?>
<rdf:RDF xmlns="http://ontofox.hegroup.org/5kzfqaeq.owl#"
     xml:base="http://ontofox.hegroup.org/5kzfqaeq.owl"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:efo="http://www.ebi.ac.uk/efo/"
     xmlns:obo="http://purl.obolibrary.org/obo/"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:skos="http://www.w3.org/2004/02/skos/core#"
     xmlns:mondo="http://purl.obolibrary.org/obo/mondo#"
     xmlns:terms="http://purl.org/dc/terms/"
     xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#"
     xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#">
    <owl:Ontology rdf:about="http://ontofox.hegroup.org/disease_1.owl"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/IAO_0000111 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000111"/>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000114 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000114">
        <obo:IAO_0000111 xml:lang="en">has curation status</obo:IAO_0000111>
        <rdfs:label xml:lang="en">has curation status</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000115 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115">
        <obo:IAO_0000116 xml:lang="en">2012-04-05: 
Barry Smith

The official OBI definition, explaining the meaning of a class or property: &apos;Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions&apos;  is terrible.

Can you fix to something like:

A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property.

Alan Ruttenberg

Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can&apos;t be evaluated by those criteria. 

On the specifics of the proposed definition:

We don&apos;t have definitions of &apos;meaning&apos; or &apos;expression&apos; or &apos;property&apos;. For &apos;reference&apos; in the intended sense I think we use the term &apos;denotation&apos;. For &apos;expression&apos;, I think we you mean symbol, or identifier. For &apos;meaning&apos; it differs for class and property. For class we want documentation that let&apos;s the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let&apos;s the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The &apos;intended reader&apos; part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition. 

Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable. 

We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with.  </obo:IAO_0000116>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000116 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000116">
        <obo:IAO_0000119 xml:lang="en">GROUP:OBI:&lt;http://purl.obofoundry.org/obo/obi&gt;</obo:IAO_0000119>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000119 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000119">
        <obo:IAO_0000111 xml:lang="en">definition source</obo:IAO_0000111>
        <obo:IAO_0000119 xml:lang="en">Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w</obo:IAO_0000119>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000233 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000233">
        <obo:IAO_0000111 xml:lang="en">term tracker item</obo:IAO_0000111>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000125"/>
        <obo:IAO_0000115 xml:lang="en">An IRI or similar locator for a request or discussion of an ontology term.</obo:IAO_0000115>
        <obo:IAO_0000119 xml:lang="en">Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg</obo:IAO_0000119>
        <rdfs:comment xml:lang="en">The &apos;tracker item&apos; can associate a tracker with a specific ontology term.</rdfs:comment>
        <rdfs:label xml:lang="en">term tracker item</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000412 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000412">
        <rdfs:label xml:lang="en">imported from</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000589 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000589">
        <obo:IAO_0000111 xml:lang="en">OBO foundry unique label</obo:IAO_0000111>
        <obo:IAO_0000114 rdf:resource="http://purl.obolibrary.org/obo/IAO_0000125"/>
        <obo:IAO_0000115 xml:lang="en">An alternative name for a class or property which is unique across the OBO Foundry.</obo:IAO_0000115>
        <obo:IAO_0000116 xml:lang="en">The intended usage of that property is as follow: OBO foundry unique labels are automatically generated based on regular expressions provided by each ontology, so that SO could specify unique label = &apos;sequence &apos; + [label], etc. , MA could specify &apos;mouse + [label]&apos; etc. Upon importing terms, ontology developers can choose to use the &apos;OBO foundry unique label&apos; for an imported term or not. The same applies to tools .</obo:IAO_0000116>
        <obo:IAO_0000119 xml:lang="en">GROUP:OBO Foundry &lt;http://obofoundry.org/&gt;</obo:IAO_0000119>
        <rdfs:label xml:lang="en">OBO foundry unique label</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A23 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A23">
        <obo:IAO_0000115>An association that specifies one of three data types for a particular variable, String, Code or Number.</obo:IAO_0000115>
        <obo:NCIT_NHC0>A23</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Has_PCDC_Data_Type</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Has_PCDC_Data_Type</oboInOwl:hasExactSynonym>
        <rdfs:label>Has_PCDC_Data_Type</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#anyURI"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A28 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A28">
        <obo:IAO_0000115>An association that indicates a PCDC EWS concept is a Permissible Value for a specific PCDC EWS Variable concept.</obo:IAO_0000115>
        <obo:NCIT_NHC0>A28</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Is_PCDC_EWS_Permissible_Value_For_Variable</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Is_PCDC_EWS_Permissible_Value_For_Variable</oboInOwl:hasExactSynonym>
        <rdfs:label>Is_PCDC_EWS_Permissible_Value_For_Variable</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#anyURI"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A29 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A29">
        <obo:IAO_0000115>An association that shows which Permissible Values are possible for a specific PCDC EWS Variable concept.</obo:IAO_0000115>
        <obo:NCIT_NHC0>A29</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Has_PCDC_EWS_Permissible_Value</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Has_PCDC_EWS_Permissible_Value</oboInOwl:hasExactSynonym>
        <rdfs:label>Has_PCDC_EWS_Permissible_Value</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#anyURI"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A30 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A30">
        <obo:IAO_0000115>An association connecting an ICDC Property concept to its dedicated permissible value concept(s).</obo:IAO_0000115>
        <obo:NCIT_NHC0>A30</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Has_ICDC_Value</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Has_ICDC_Value</oboInOwl:hasExactSynonym>
        <rdfs:label>Has_ICDC_Value</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A31 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A31">
        <obo:IAO_0000115>An association that connects a concept representing a GDC property to its dedicated permissible value concept(s).</obo:IAO_0000115>
        <obo:NCIT_NHC0>A31</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Has_GDC_Value</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Has_GDC_Value</oboInOwl:hasExactSynonym>
        <rdfs:label>Has_GDC_Value</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A32 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A32">
        <obo:IAO_0000115>An association that that connects a concept representing a GDC value to any associated GDC property concept(s).</obo:IAO_0000115>
        <obo:NCIT_NHC0>A32</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Is_Value_For_GDC_Property</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Is_Value_For_GDC_Property</oboInOwl:hasExactSynonym>
        <rdfs:label>Is_Value_For_GDC_Property</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#anyURI"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A33 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A33">
        <obo:IAO_0000115>An association that indicates a concept is a dedicated Permissible Value concept for a specific PCDC GCT Variable.</obo:IAO_0000115>
        <obo:NCIT_NHC0>A33</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Is_PCDC_GCT_Permissible_Value_For_Variable</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Is_PCDC_GCT_Permissible_Value_For_Variable</oboInOwl:hasExactSynonym>
        <rdfs:label>Is_PCDC_GCT_Permissible_Value_For_Variable</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#anyURI"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A34 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A34">
        <obo:IAO_0000115>An association that shows which Permissible Values are possible for a specific PCDC GCT Variable.</obo:IAO_0000115>
        <obo:NCIT_NHC0>A34</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Has_PCDC_GCT_Permissible_Value</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Has_PCDC_GCT_Permissible_Value</oboInOwl:hasExactSynonym>
        <rdfs:label>Has_PCDC_GCT_Permissible_Value</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#anyURI"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A35 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A35">
        <obo:IAO_0000115>An association that indicates a concept contains dedicated permissible value concept for a specific PCDC ALL Variable.</obo:IAO_0000115>
        <obo:NCIT_NHC0>A35</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Is_PCDC_ALL_Permissible_Value_For_Variable</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Is_PCDC_ALL_Permissible_Value_For_Variable</oboInOwl:hasExactSynonym>
        <rdfs:label>Is_PCDC_ALL_Permissible_Value_For_Variable</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#anyURI"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A38 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A38">
        <obo:IAO_0000115>An association that shows which Permissible Values are possible for a specific PCDC OS Variable.</obo:IAO_0000115>
        <obo:NCIT_NHC0>A38</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Has_PCDC_OS_Permissible_Value</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Has_PCDC_OS_Permissible_Value</oboInOwl:hasExactSynonym>
        <rdfs:label>Has_PCDC_OS_Permissible_Value</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#anyURI"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A39 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A39">
        <obo:IAO_0000115>An association that shows which Permissible Values are possible for a specific PCDC HL Variable.</obo:IAO_0000115>
        <obo:NCIT_NHC0>A39</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Has_PCDC_HL_Permissible_Value</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Has_PCDC_HL_Permissible_Value</oboInOwl:hasExactSynonym>
        <rdfs:label>Has_PCDC_HL_Permissible_Value</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#anyURI"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_A7 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_A7">
        <obo:IAO_0000115>An association that connects a drug or other agent to a clinically intended, molecular-scale target. The target value may be a gene, gene product, anatomic structure, cell, biological process, or other concept, where the effect of the agent on the target is thought to be of therapeutic, diagnostic, or other clinical relevance to a disease process. The effect is most often direct, as defined at a molecular scale, but may also be indirect and/or defined at a larger scale.</obo:IAO_0000115>
        <obo:NCIT_NHC0>A7</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P107>Has Target</obo:NCIT_P107>
        <obo:NCIT_P108>Has_Target</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Has_Target</oboInOwl:hasExactSynonym>
        <rdfs:label>Has_Target</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#anyURI"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_NHC0 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_NHC0"/>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P106 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P106">
        <rdfs:range rdf:resource="http://purl.obolibrary.org/obo/NCIT_Semantic_Type-enum"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P107 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P107">
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P108 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P108">
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P171 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P171">
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P207 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P207">
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P208 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P208"/>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P210 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P210"/>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P319 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P319">
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P322 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P322"/>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P325 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P325"/>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P350 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P350">
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P366 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P366">
        <obo:IAO_0000115>A property representing a retired unique concept identifier created and stored as Concept Name by legacy EVS software. Use of these values was long discouraged, but continued as late as 2009 when creation of new values ceased and Concept Name was retired. Legacy values are intended solely to help resolve and update earlier coding.</obo:IAO_0000115>
        <obo:NCIT_NHC0>P366</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Legacy Concept Name</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Legacy Concept Name</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Legacy_Concept_Name</oboInOwl:hasExactSynonym>
        <rdfs:label>Legacy Concept Name</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P368 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P368">
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P375 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P375">
        <obo:IAO_0000115>A property representing that a term in another terminology has been mapped to a term in NCIt and describes the relationship between the mapped terms.</obo:IAO_0000115>
        <obo:NCIT_NHC0>P375</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Maps_To</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>Maps_To</oboInOwl:hasExactSynonym>
        <rdfs:label>Maps_To</rdfs:label>
        <rdfs:range rdf:resource="http://purl.obolibrary.org/obo/NCIT_textArea"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P399 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P399">
        <obo:IAO_0000115>A property representing the numerical CDR ID, which is the NCI Drug Dictionary identifier for a chemical or pharmaceutical agent.</obo:IAO_0000115>
        <obo:NCIT_NHC0>P399</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>NCI_Drug_Dictionary_ID</obo:NCIT_P108>
        <oboInOwl:hasExactSynonym>NCI_Drug_Dictionary_ID</oboInOwl:hasExactSynonym>
        <rdfs:label>NCI_Drug_Dictionary_ID</rdfs:label>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_P98 -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/NCIT_P98">
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/elements/1.1/date -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/date"/>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#hasAlternativeId -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasAlternativeId">
        <rdfs:label>has_alternative_id</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#hasBroadSynonym -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasBroadSynonym">
        <rdfs:label>has_broad_synonym</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#hasDbXref -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasDbXref">
        <obo:IAO_0000115>A property representing a reference to an identical or very similar object in another database.</obo:IAO_0000115>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>xRef</obo:NCIT_P108>
        <rdfs:label>xRef</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#hasExactSynonym -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasExactSynonym">
        <obo:IAO_0000115>A property representing a fully qualified synonym, contains the string, term type, source, and an optional source code if appropriate. Each subfield is deliniated to facilitate interpretation by software.</obo:IAO_0000115>
        <obo:IAO_0000115>An alternative label for a given entity such as a commonly used abbreviation or synonym. </obo:IAO_0000115>
        <oboInOwl:hasExactSynonym>FULL_SYN</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Synonym with Source Data</oboInOwl:hasExactSynonym>
        <rdfs:label>has exact synonym</rdfs:label>
        <rdfs:label>has_exact_synonym</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#hasNarrowSynonym -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasNarrowSynonym">
        <rdfs:label>has_narrow_synonym</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#hasOBONamespace -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasOBONamespace">
        <rdfs:label>has_obo_namespace</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#hasRelatedSynonym -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasRelatedSynonym">
        <rdfs:label>has_related_synonym</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#id -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#id"/>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#inSubset -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#inSubset">
        <obo:IAO_0000115>An association that connects the concept defining a particular terminology subset with concepts that belong to this subset.</obo:IAO_0000115>
        <oboInOwl:hasExactSynonym>Concept_In_Subset</oboInOwl:hasExactSynonym>
        <rdfs:label>in subset</rdfs:label>
        <rdfs:label>in_subset</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#is_class_level -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#is_class_level"/>
    


    <!-- http://www.geneontology.org/formats/oboInOwl#is_metadata_tag -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#is_metadata_tag"/>
    


    <!-- http://www.w3.org/2000/01/rdf-schema#comment -->

    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#comment"/>
    


    <!-- http://www.w3.org/2000/01/rdf-schema#label -->

    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#label">
        <rdfs:label>label</rdfs:label>
    </owl:AnnotationProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/BTO_0001133 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/BTO_0001133">
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/bto.owl"/>
        <oboInOwl:hasOBONamespace>BrendaTissueOBO</oboInOwl:hasOBONamespace>
        <oboInOwl:hasRelatedSynonym>B cell precursor</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>B-cell precursor</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>pre-B cell</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>pre-B-cell</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>BTO:0001133</oboInOwl:id>
        <rdfs:label>pre-B-lymphocyte</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/HP_0005550 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/HP_0005550">
        <obo:IAO_0000115>A chronic lymphocytic/lymphatic/lymphoblastic leukemia (CLL) is a neoplastic disease characterized by proliferation and accumulation (blood, marrow and lymphoid organs) of morphologically mature but immunologically dysfunctional lymphocytes. A CLL is always a B-cell lymphocytic leukemia as there are no reports of cases of T-cell lymphocytic leukemias.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/hp.owl"/>
        <oboInOwl:hasAlternativeId>HP:0006734</oboInOwl:hasAlternativeId>
        <oboInOwl:hasAlternativeId>HP:0006760</oboInOwl:hasAlternativeId>
        <oboInOwl:hasDbXref>MSH:D015451</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SNOMEDCT_US:277473004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SNOMEDCT_US:51092000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SNOMEDCT_US:92814006</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0023434</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Chronic lymphatic leukaemia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Chronic lymphocytic leukaemia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Chronic lymphocytic leukemia</oboInOwl:hasExactSynonym>
        <oboInOwl:id>HP:0005550</oboInOwl:id>
        <rdfs:label>Chronic lymphatic leukemia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/HP_0025297 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/HP_0025297">
        <obo:IAO_0000115>Applied to an abnormality whose duration is extended over a longer period of time than is expected or usual (e.g., prolonged fever lasts longer than one usually sees with an infection).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/hp.owl"/>
        <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-12-18T16:26:30Z</dc:date>
        <rdfs:label xml:lang="en">Prolonged</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/HP_0100582 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/HP_0100582">
        <obo:IAO_0000115>Polypoidal masses arising mainly from the mucous membranes of the nose and paranasal sinuses. They are freely movable and nontender overgrowths of the mucosa that frequently accompany allergic rhinitis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/hp.owl"/>
        <oboInOwl:hasAlternativeId>HP:0000462</oboInOwl:hasAlternativeId>
        <oboInOwl:hasDbXref>MSH:D009298</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SNOMEDCT_US:52756005</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0027430</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Nasal polyps</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Polyposis nasi</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Polyps of nose</oboInOwl:hasExactSynonym>
        <oboInOwl:id>HP:0100582</oboInOwl:id>
        <rdfs:comment>Nasal polyps (NP) are benign lesions arising from the mucosa of the nasal sinuses (commonly at the outflow tract of one or more of the sinuses) or from the mucosa of the nasal cavity. The main presenting symptom of NP is nasal obstruction which is constant but can vary depending on the site and size of the polyps. Sufferers will also frequently complain of watery rhinorrhea and postnasal drip. Anosmia or hyposmia with an ensuing alteration in taste are also characteristic symptoms of NP.</rdfs:comment>
        <rdfs:label>Nasal polyposis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0000001 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0000001">
        <obo:IAO_0000115>A disease is a disposition to undergo pathological processes that exists in an organism because of one or more disorders in that organism.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:4</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000408</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:799.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D004194</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C2991</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>OGMS:0000031</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:377788</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:64572001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0012634</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>condition</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder, non-neoplastic</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>diseases</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>diseases and disorders</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorders</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>medical condition</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>other disease</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0000001</oboInOwl:id>
        <rdfs:label>disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0000226 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0000226">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005066"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>ICD10CM:E83</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:275.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:275.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:45744005</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of mineral metabolism</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of mineral metabolism</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0000226</oboInOwl:id>
        <rdfs:label>mineral metabolism disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0000314 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0000314">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005113"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0050338</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0000314</oboInOwl:id>
        <rdfs:label>primary bacterial infectious disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0000462 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0000462">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002022"/>
        <obo:IAO_0000115>A disease involving the ocular adnexa.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0050815</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10WHO:H00-H06</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:519266</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:118941004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C1290855</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of ocular adnexa</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of ocular adnexa</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of ocular adnexa</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ocular adnexa disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ocular adnexa disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0000462</oboInOwl:id>
        <rdfs:label>eye adnexa disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0000591 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0000591">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0004994"/>
        <obo:IAO_0000115>A cardiomyopathy that is due to abnormalities in heart muscle cells.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0060036</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>intrinsic cardiomyopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>primary cardiomyopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0000591</oboInOwl:id>
        <rdfs:label>intrinsic cardiomyopathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0000833 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0000833">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005381"/>
        <obo:IAO_0000115>A bone disease that results in formation or resorption abnormalities located in bone.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0080005</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0000833</oboInOwl:id>
        <rdfs:label>bone remodeling disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0001068 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0001068">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0000833"/>
        <obo:IAO_0000115>A metabolic bone disease that results from either a deficiency in vitamin D, or an abnormality in the metabolism of vitamin D, or a deficiency of calcium in the diet. The most common symptoms are bone pain and muscle weakness. When it occurs in children it is commonly referred to as rickets. (Diagnostic Surgical Pathology, 3rd ed.) --2003</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <obo:IAO_0000589>osteomalacia (disease)</obo:IAO_0000589>
        <oboInOwl:hasDbXref>DOID:10573</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:1002027</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>GARD:0007285</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>HP:0002749</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:268.2</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D010018</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C26838</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:4598005</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>osteomalacia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>osteomalacia (disease)</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0001068</oboInOwl:id>
        <rdfs:label>osteomalacia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0001336 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0001336">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002525"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0021187"/>
        <obo:IAO_0000115>An instance of hyperlipidemia (disease) that is caused by an inherited modification of the individual&apos;s genome.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasBroadSynonym>hyperlipemia</oboInOwl:hasBroadSynonym>
        <oboInOwl:hasBroadSynonym>hyperlipidaemia</oboInOwl:hasBroadSynonym>
        <oboInOwl:hasDbXref>DOID:1168</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:E78.5</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D006949</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C34709</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:55822004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0020473</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0020476</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>hereditary hyperlipidemia (disease)</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>familial hyperlipemia</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>familial hyperlipoproteinemia</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0001336</oboInOwl:id>
        <rdfs:label>familial hyperlipidemia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0001509 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0001509">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0004751"/>
        <obo:IAO_0000115>Progressive inflammation and damage to tissues around the eyes, especially extraocular muscle, connective, and fatty tissue occurring in patients with hyperthyroidism or a history of hyperthyroidism due to Graves’ disease.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/5472</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:12359</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:376.2</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:276177000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0155264</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Graves’ eye disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Graves’ ophthalmopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Graves’ orbitopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>TED</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>thyroid eye disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>thyroid-associated ophthalmopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0001509</oboInOwl:id>
        <rdfs:label>endocrine exophthalmos</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0001511 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0001511">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0001509"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:12362</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:376.21</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:19885005</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0155265</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0001511</oboInOwl:id>
        <rdfs:label>thyrotoxic exophthalmos</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0001566 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0001566">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005557"/>
        <obo:IAO_0000115>Abnormally high concentration of calcium in the peripheral blood.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:12678</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>HP:0003072</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:E83.52</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:275.42</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D006934</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3112</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:66931009</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0020437</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>hypercalcemia</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0001566</oboInOwl:id>
        <rdfs:label>hypercalcemia disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0001584 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0001584">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003569"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:1279</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:1001990</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>GARD:0007237</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:378.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:45030009</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disorder of eye movements</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>eye movement disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0001584</oboInOwl:id>
        <rdfs:label>ocular motility disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0001643 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0001643">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0001509"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0001835"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003425"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:13135</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:376.22</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:69763009</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0152135</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0001643</oboInOwl:id>
        <rdfs:label>exophthalmic ophthalmoplegia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0001835 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0001835">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0006496"/>
        <obo:IAO_0000115>Severe or complete loss of facial muscle motor function. This condition may result from central or peripheral lesions. Damage to CNS motor pathways from the cerebral cortex to the facial nuclei in the pons leads to facial weakness that generally spares the forehead muscles. facial nerve diseases generally results in generalized hemifacial weakness. neuromuscular junction diseases and muscular diseases may also cause facial paralysis or paresis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:13934</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D005158</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:280816001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0015469</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>face palsy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>facial palsy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>palsy of face</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0001835</oboInOwl:id>
        <rdfs:label>facial paralysis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002022 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002022">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease that involves the orbital region.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:1492</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:H00-H59</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:362.10</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:371409005</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of orbital region</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of orbital region</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of eye region</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of orbital region</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>orbital region disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>orbital region disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>eye and adnexa disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>ophthalmological disorder</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0002022</oboInOwl:id>
        <rdfs:label>disorder of orbital region</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002051 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002051">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease involving the integumental system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasAlternativeId>MONDO:0045027</oboInOwl:hasAlternativeId>
        <oboInOwl:hasDbXref>DOID:16</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:128598002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C1290011</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of integumental system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of integumental system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of integumental system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>integumental system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>integumental system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>integumentary disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>disorder of integument</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0002051</oboInOwl:id>
        <rdfs:label>integumentary system disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002081 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002081">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease involving the musculoskeletal system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:17</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:729.99</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D009140</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C107377</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:928000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0026857</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of musculoskeletal system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of musculoskeletal system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of musculoskeletal system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>musculoskeletal disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>musculoskeletal system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>musculoskeletal system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>musculoskeletal system disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>musculoskeletal disorder</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0002081</oboInOwl:id>
        <rdfs:label>musculoskeletal system disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002118 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002118">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease involving the renal system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:18</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:V47.4</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D014570</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3430</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:128606002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C1335051</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of renal system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of renal system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease, urinary tract</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease, urologic</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease, urological</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>diseases, urinary tract</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>diseases, urologic</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>diseases, urological</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of renal system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of the urinary system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of urinary system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>non-neoplastic urinary tract disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>renal system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>renal system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urinary disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urinary system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urinary system disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urinary tract disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urinary tract diseases</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urinary tract disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urologic disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urologic disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urological disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urological diseases</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urological disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>urological disorders</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0002118</oboInOwl:id>
        <rdfs:label>urinary system disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002254 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002254">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:225</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D013577</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C28193</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>OGMS:0000086</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0039082</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>cluster, symptom</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>clusters, symptom</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>symptom cluster</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>symptom clusters</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>syndrome</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>syndrome associated with disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>syndromes</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>syndromic disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>syndromic disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0002254</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#harrisons_view"/>
        <rdfs:label>syndromic disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002260 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002260">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0021166"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0024467"/>
        <obo:IAO_0000115>An inflammatory disease involving a pathogenic inflammatory response in the apocrine sweat gland.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:2282</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:705.83</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D016575</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C32132</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:69741000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0085160</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Hydradenitis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>apocrine sweat gland</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>apocrine sweat gland inflammation</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inflammation of apocrine sweat gland</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0002260</oboInOwl:id>
        <rdfs:label>hidradenitis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002311 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002311">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005283"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005552"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0043218"/>
        <obo:IAO_0000115>Retinal damage resulting from diminished blood flow/oxygenation due to abnormalities of the retinal vessels. Causes include hypertension, diabetes, thrombosis, embolism, and hemorrhage.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:2462</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:362.13</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C35170</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:57534004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0154833</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>retina circulation disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>retinal vascular disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0002311</oboInOwl:id>
        <rdfs:label>retinal vascular disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002406 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002406">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005093"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0021166"/>
        <obo:IAO_0000115>An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:2723</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:1000636</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:692.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D003872</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C2983</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:43116000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0011603</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>inflammation of skin</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inflammation of the skin</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inflammation of zone of skin</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inflammatory skin disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>skin inflammation</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>zone of skin inflammation</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0002406</oboInOwl:id>
        <rdfs:label>dermatitis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002525 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002525">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0019052"/>
        <obo:IAO_0000115>An inherited metabolic disorder caused by an enzyme deficiency, resulting in an inability to oxidize fatty acids for energy production.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasBroadSynonym>disorder of lipid metabolism</oboInOwl:hasBroadSynonym>
        <oboInOwl:hasBroadSynonym>dyslipidemia</oboInOwl:hasBroadSynonym>
        <oboInOwl:hasBroadSynonym>lipid metabolism disorder</oboInOwl:hasBroadSynonym>
        <oboInOwl:hasDbXref>DOID:3146</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:272.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:272.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10061227</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C97092</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:309005</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:267431006</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0154251</oboInOwl:hasDbXref>
        <oboInOwl:hasRelatedSynonym>fatty acid metabolism disorder</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0002525</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>inherited lipid metabolism disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002602 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002602">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005071"/>
        <obo:IAO_0000115>A disease involving the central nervous system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:331</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D002493</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C2934</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:23853001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0007682</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>CNS disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>central nervous disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>central nervous system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>central nervous system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>central nervous system disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of central nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of the central nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of central nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of central nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0002602</oboInOwl:id>
        <rdfs:label>central nervous system disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0002614 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0002614">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005381"/>
        <obo:IAO_0000115>Inflammation of the bone.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:3342</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D010000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:274144001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0029400</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>bone inflammatory disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inflammatory disorder of bone</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>osteitis</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0002614</oboInOwl:id>
        <rdfs:label>bone inflammation disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0003425 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0003425">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0001584"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0006496"/>
        <obo:IAO_0000115>Weakness or paralysis of at least one of the muscles controlling the movement of the eye. It results from degeneration of the muscles or the neural pathways involved in the eye movement. Representative disorders causing ophthalmoplegia include ocular myopathies and multiple sclerosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:539</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:378.56</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D009886</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:78097002</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>total ophthalmoplegia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>oculomotor paralysis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0003425</oboInOwl:id>
        <rdfs:label>ophthalmoplegia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0003543 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0003543">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003569"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003620"/>
        <obo:IAO_0000115>A disease involving the trigeminal nerve.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:561</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:350.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D020433</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C26952</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:64309007</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of trigeminal nerve</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of trigeminal nerve</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of trigeminal nerve</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>trigeminal nerve disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>trigeminal nerve disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>trigeminal nerve disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>disorder of the fifth cranial nerve</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>disorders of the fifth nerve</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>disorders of the vth cranial nerve</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0003543</oboInOwl:id>
        <rdfs:label>trigeminal nerve disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0003569 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0003569">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005071"/>
        <obo:IAO_0000115>A neoplastic or non-neoplastic disorder that affects one of the cranial nerves.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:5656</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:352.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D003389</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C26733</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:73013002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0010266</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>cranial nerve disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cranial nerve disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cranial neuron projection bundle disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cranial neuron projection bundle disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cranial neuropathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of cranial neuron projection bundle</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of cranial neuron projection bundle</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of cranial nerve</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of cranial neuron projection bundle</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0003569</oboInOwl:id>
        <rdfs:label>cranial nerve neuropathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0003620 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0003620">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005071"/>
        <obo:IAO_0000115>A disease involving the peripheral nervous system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:574</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:350-359.99</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:356.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D010523</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C27580</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:42658009</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>PNS (peripheral nervous system) diseases</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>PNS disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>PNS diseases</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of peripheral nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of peripheral nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of peripheral nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of the peripheral nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>peripheral nervous system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>peripheral nervous system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>peripheral nervous system disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>peripheral nervous system disorders</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>nerve disease, peripheral</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>nerve diseases, peripheral</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>neuropathy, peripheral</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>peripheral Neuropathies</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>peripheral nerve disease</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>peripheral nerve diseases</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>peripheral neuropathy</oboInOwl:hasNarrowSynonym>
        <oboInOwl:id>MONDO:0003620</oboInOwl:id>
        <rdfs:label>peripheral nervous system disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0003778 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0003778">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0009453"/>
        <obo:IAO_0000115>A disorder in which the immune system is unable to mount an adequate immune response.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:612</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:279.3</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D007153</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3131</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:101997</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:234532001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:58606001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0021051</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0398686</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>IEI</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hypoimmunity</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inborn errors of immunity</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>primary immunodeficiency disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>antibody deficiency syndrome</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>antibody deficiency syndromes</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>deficiency syndrome, antibody</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>deficiency syndrome, immunologic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>deficiency syndrome, immunological</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>deficiency syndromes, antibody</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>deficiency syndromes, immunologic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>deficiency syndromes, immunological</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>immune deficiency disorder</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>immunodeficiency syndrome</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>immunologic deficiency syndrome</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>immunological deficiency syndrome</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>immunological deficiency syndromes</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>primary immunodeficiency</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndrome, antibody deficiency</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndrome, immunologic deficiency</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndrome, immunological deficiency</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndromes, antibody deficiency</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndromes, immunologic deficiency</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndromes, immunological deficiency</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0003778</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>inborn error of immunity</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0003847 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0003847">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease that is caused by genetic modifications where those modifications are inherited from a parent&apos;s genome.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasBroadSynonym>genetic condition</oboInOwl:hasBroadSynonym>
        <oboInOwl:hasBroadSynonym>genetic disease</oboInOwl:hasBroadSynonym>
        <oboInOwl:hasBroadSynonym>genetic disorder</oboInOwl:hasBroadSynonym>
        <oboInOwl:hasDbXref>DOID:630</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000508</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:799.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D030342</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3101</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:32895009</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0019247</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>hereditary disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hereditary disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hereditary diseases</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inherited disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inherited genetic disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>molecular disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>Mendelian disease</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasRelatedSynonym>familial disorder</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>inborn disorder</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0003847</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#harrisons_view"/>
        <rdfs:comment>Usage note: this is intended only for diseases with an inherited genetic etiology. Somatic genetic mutations are excluded. Some ontologies use the term &apos;genetic disease&apos; in the sense of inherited disorders only, we are here careful to distinguish.</rdfs:comment>
        <rdfs:label>hereditary disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0003900 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0003900">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease involving the connective tissue.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/3570</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:65</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D003240</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C26729</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:105969002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0009782</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>connective tissue disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>connective tissue disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>connective tissue diseases</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>connective tissue disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>connective tissue disorders</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of connective tissue</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of connective tissue</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease, connective tissue</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of connective tissue</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>primary disorder of connective tissue</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>tissue disease, connective</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0003900</oboInOwl:id>
        <rdfs:comment>Following clinical usage of the term &apos;connective tissue disorder&apos; this grouping excludes some diseases affecting tissues classically considered to be connective tissue, such as bone.</rdfs:comment>
        <rdfs:label>connective tissue disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0003939 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0003939">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002081"/>
        <obo:IAO_0000115>A disease involving the muscle tissue.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/5166</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0080000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>DOID:66</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0002970</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:M60-M63</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D009135</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of muscle organ</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of muscle tissue</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of muscle organ</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of muscle tissue</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of muscle organ</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of muscle tissue</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>muscle organ disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>muscle organ disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>muscle tissue disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>muscle tissue disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>muscular disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0003939</oboInOwl:id>
        <rdfs:label>muscle tissue disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0004728 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0004728">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005266"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:9191</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:362.07</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:312912001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0730285</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0004728</oboInOwl:id>
        <rdfs:label>diabetic macular edema</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0004751 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0004751">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0000462"/>
        <obo:IAO_0000115>Diseases of the bony orbit and contents except the eyeball.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:930</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:376</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:376.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D009916</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0029182</oboInOwl:hasDbXref>
        <oboInOwl:hasRelatedSynonym>orbital disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0004751</oboInOwl:id>
        <rdfs:comment>Editor note: check this. MESH and DOID excludes eyeball which would make equivalent to adnexa</rdfs:comment>
        <rdfs:label>disease of orbital part of eye adnexa</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0004994 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0004994">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003939"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005267"/>
        <obo:IAO_0000115>A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0050700</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000318</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>GARD:0011958</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:I42</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:425</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:425.4</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:425.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D009202</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10007636</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C34830</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:167848</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:57809008</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:85898001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0878544</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Cardiomyopathies</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cardiomyopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0004994</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>cardiomyopathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0004995 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0004995">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease involving the cardiovascular system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:1287</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000319</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:390-459.99</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:420-429.99</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:423</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:423.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:424</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:429</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:429.2</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:429.7</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:429.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:429.81</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:429.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:459.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:459.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D002318</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C2931</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:49601007</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0007222</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>cardiovascular disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cardiovascular disease (CVD)</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cardiovascular disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cardiovascular system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cardiovascular system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of cardiovascular system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of subdivision of hemolymphoid system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of cardiovascular system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of cardiovascular system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>circulatory system disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0004995</oboInOwl:id>
        <rdfs:label>cardiovascular disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005045 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005045">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0000591"/>
        <obo:IAO_0000115>A condition in which the myocardium is hypertrophied without an obvious cause. The hypertrophy is generally asymmetric and may be associated with obstruction of the ventricular outflow tract.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/5962</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:11984</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000538</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>HP:0001639</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:I42.1</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:425.1</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:425.11</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:425.4</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D002312</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10020871</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C34449</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:217569</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:233873004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0007194</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>hypertrophic cardiomyopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hypertrophic obstructive cardiomyopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hypertrophic subaortic stenosis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>obstructive hypertrophic cardiomyopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>familial hypertrophic cardiomyopathy</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasRelatedSynonym>HCM - hypertrophic cardiomyopathy</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005045</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#clingen"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>hypertrophic cardiomyopathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005046 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005046">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disorder resulting from an abnormality in the immune system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:2914</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000540</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:279</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:279.1</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:279.10</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:279.19</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:279.4</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:279.49</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:279.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:279.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D007154</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3507</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:414029004</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of immune system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of immune system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of immune system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>immune disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>immune disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>immune dysfunction</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>immune system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>immune system disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0005046</oboInOwl:id>
        <rdfs:label>immune system disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005066 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005066">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A congenital disorder (due to inherited enzyme abnormality) or acquired (due to failure of a metabolically important organ) disorder resulting from an abnormal metabolic process.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0014667</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000589</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:E70-E88</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10WHO:E70-E90</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:277.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:277.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D008659</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3235</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:75934005</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0025517</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disorder of metabolic process</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>metabolic disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>metabolic disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>metabolic process disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>disease of metabolism</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005066</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#harrisons_view"/>
        <rdfs:label>metabolic disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005071 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005071">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000618</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:G00-G99</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:349.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:349.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D009422</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C26835</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:118940003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0027765</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Wikipedia:Nervous_system_disease</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of nervous system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>nervous system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>nervous system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>nervous system disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>neurologic disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>neurologic disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>neurological disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>neurological disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0005071</oboInOwl:id>
        <rdfs:comment>&apos;psychiatric disorder&apos; is not classified as a &apos;nervous system disorder&apos; in Mondo (though it is often as such): the hallmarks of psychiatric disorders are based in behavior and emotional state, and the relation with nervous system malfunction or damage is not always clearly determined.</rdfs:comment>
        <rdfs:label>nervous system disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005083 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005083">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002406"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005046"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0100118"/>
        <obo:IAO_0000115>An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:8893</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000676</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>GARD:0010262</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:L40</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:696</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:696.1</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:696.5</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:696.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D011565</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3346</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>OMIMPS:177900</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:9014002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0033860</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0005083</oboInOwl:id>
        <rdfs:label>psoriasis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005093 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005093">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002051"/>
        <obo:IAO_0000115>Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:37</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000701</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:702</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:702.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:709.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D012871</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3371</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:95320005</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>cutaneous disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of zone of skin</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of zone of skin</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of skin</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of zone of skin</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>skin and subcutaneous tissue disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>skin diseases and manifestations</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>skin disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>zone of skin disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>zone of skin disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>dermatosis</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>genodermatosis</oboInOwl:hasNarrowSynonym>
        <oboInOwl:id>MONDO:0005093</oboInOwl:id>
        <rdfs:label>skin disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005113 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005113">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005550"/>
        <obo:IAO_0000115>An acute infectious disorder that is caused by gram positive or gram negative bacteria; representative examples include pneumococcal, streptococcal, salmonella, and meningeal infections.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:104</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000771</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:040.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:041.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:041.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D001424</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C2890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:87628006</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0004623</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Bacteria caused disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Bacteria disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Bacteria infectious disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>bacterial disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>bacterial disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>bacterial infection</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>bacterial infectious disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>infection, bacterial</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>infections, bacterial</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005113</oboInOwl:id>
        <rdfs:label>bacterial infectious disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005119 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005119">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0000314"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0006923"/>
        <obo:IAO_0000115>An infection caused by Bacillus anthracis bacteria. It may affect the lungs, gastrointestinal tract, or skin. Patients with lung infection present with fever, headaches, cough, chest pain and shortness of breath. Patients with gastrointestinal infection present with nausea, vomiting and bloody diarrhea. Patients with skin infection develop blisters and ulcers.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:7427</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0000778</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>GARD:0008157</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:022</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:022.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:022.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D000881</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C84565</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:409498004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0003175</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Bacillus anthracis caused disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Bacillus anthracis disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Bacillus anthracis infectious disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>anthrax</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>anthrax disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005119</oboInOwl:id>
        <rdfs:comment>Editor note: DOID says skin disease but we suppress this as it would be identical to subclass skin anthrax</rdfs:comment>
        <rdfs:label>anthrax infection</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005151 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005151">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease involving the endocrine system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:28</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0001379</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:259.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:259.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D004700</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3009</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:362969004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0014130</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of endocrine system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of endocrine system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of endocrine system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>endocrine disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>endocrine disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>endocrine system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>endocrine system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>endocrine system disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>endocrinopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>thyroid or other glandular disorders</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0005151</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#harrisons_view"/>
        <rdfs:label>endocrine system disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005172 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005172">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002081"/>
        <obo:IAO_0000115>A disease involving the skeletal system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>EFO:0002461</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:88230002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0263661</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of skeletal system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of skeletal system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of skeletal system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>skeletal system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>skeletal system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>disease of bone and/or joint</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>osteoarthropathy</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005172</oboInOwl:id>
        <rdfs:label>skeletal system disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005201 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005201">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0000591"/>
        <obo:IAO_0000115>A type of heart disorder referring to the inability of the ventricles to fill with blood because the myocardium (heart muscle) stiffens and looses its flexibility. Causes include replacement of the myocardium with scar tissue, abnormal cellular infiltration of the myocardium, or deposition of a substance (e.g., amyloid) in the myocardium.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:397</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0002630</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:425.4</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D002313</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10038748</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C62798</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:217632</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:415295002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0007196</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>cardiomyopathy, constrictive</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>primary restrictive cardiomyopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>restrictive cardiomyopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>familial restrictive cardiomyopathy</oboInOwl:hasNarrowSynonym>
        <oboInOwl:id>MONDO:0005201</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>restrictive cardiomyopathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005240 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005240">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002118"/>
        <obo:IAO_0000115>A disease involving the kidney.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:557</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0003086</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:583.81</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D007674</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3149</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:90708001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0022658</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of kidney</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of kidney</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of kidney</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>kidney disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>kidney disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>kidney disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>renal disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>renal disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>nephropathy</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005240</oboInOwl:id>
        <rdfs:label>kidney disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005244 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005244">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003620"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0019056"/>
        <obo:IAO_0000115>A disorder affecting the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:870</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0003100</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0004149</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10034606</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C119734</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C4731</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:386033004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0442874</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>neuropathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>peripheral nerve disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>peripheral neuropathy</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0005244</oboInOwl:id>
        <rdfs:comment>Editor note: NCIT draws a distinction between neuropathy and peripheral neuropathy see https://github.com/NCI-Thesaurus/thesaurus-obo-edition/issues/20</rdfs:comment>
        <rdfs:label>peripheral neuropathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005266 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005266">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002311"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005066"/>
        <obo:IAO_0000115>A chronic, pathological complication associated with diabetes mellitus, where retinal damages are incurred due to microaneurysms in the vasculature of the retina, progressively leading to abnormal blood vessel growth, and swelling and leaking of fluid from blood vessels, resulting in vision loss or blindness.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:8947</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0003770</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:362.0</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D003930</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C34538</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:4855003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0011884</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>retinal abnormality - diabetes-related</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0005266</oboInOwl:id>
        <rdfs:label>diabetic retinopathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005267 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005267">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0004995"/>
        <obo:IAO_0000115>A disease involving the heart and/or pericardium.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:114</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0003777</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:429.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:429.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:V47.2</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D006331</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3079</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:56265001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0018799</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN236661</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN239852</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>cardiac disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of heart</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of heart</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of heart</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of heart/pericardium</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>heart disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>heart disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>heart disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>heart trouble</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>heart/pericardial disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>heart/pericardial disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>heart/pericardial disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>heart/pericardial trouble</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0005267</oboInOwl:id>
        <rdfs:label>heart disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005283 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005283">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005071"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005328"/>
        <obo:IAO_0000115>Any disease or disorder of the retina.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:5679</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0003839</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>HGNC:8002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:362.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:362.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D012164</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C26875</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C62601</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:29555009</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0035309</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>eye disease of retina</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>retina eye disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>retinopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0005283</oboInOwl:id>
        <rdfs:label>retinal disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005328 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005328">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002022"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0024458"/>
        <obo:IAO_0000115>A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/5166</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:1242</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>DOID:5614</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0003966</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:360</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:360.29</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:360.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:360.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:379.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:379.90</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D005128</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C26767</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:371405004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0015397</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of eye</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of eyeball of camera-type eye</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of eyeball of camera-type eye</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of eye</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of eyeball of camera-type eye</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>eye disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>eye disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>eyeball of camera-type eye disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>eyeball of camera-type eye disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>globe disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>disease of eyeball</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>disorder of eye proper</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>disorder of eyeball</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>disorder of globe</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005328</oboInOwl:id>
        <rdfs:label>eye disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005381 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005381">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005172"/>
        <obo:IAO_0000115>Diseases of bones.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0080001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0004260</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:M80-M85</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:731.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:733.99</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D001847</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:364803</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:76069003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0005940</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN204768</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>bone element disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>bone element disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of bone element</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of bone element</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of bone element</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>rare bone disease related to a common gene or pathway defect</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>skeletal disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005381</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>bone disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005385 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005385">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0004995"/>
        <obo:IAO_0000115>A general term used to describe any disease affecting blood vessels]. It includes vascular abnormalities caused by degenerative, metabolic and inflammatory conditions, embolic diseases, coagulative disorders, and functional disorders such as posteri or reversible encephalopathy syndrome.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/3602</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:178</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0004264</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:I00-I99</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:I70-I79</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:442.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D014652</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C35117</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:27550009</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0042373</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of vasculature</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of vasculature</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of vasculature</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>vascular disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>vascular tissue disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>vasculature disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>vasculature disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>vasculopathy</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005385</oboInOwl:id>
        <rdfs:comment>The etiology of vasculopathy is generally unknown and the condition is frequently not pathologically proven. Vasculitis, on the other hand, is a more specific term and is defined as inflammation of the wall of a blood vessel. However, the term vasculopathy is also used for “vasculitis” that has not been pathologically established.</rdfs:comment>
        <rdfs:label>vascular disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005439 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005439">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0001336"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0037748"/>
        <obo:IAO_0000115>An inheritable form of hyperlipidemia, in which there are excess lipids in the blood.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:13810</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0004911</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:V19.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C34704</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>OMIMPS:143890</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:477811</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:190773008</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN118841</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Fredrickson type IIa hyperlipoproteinemia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Fredrickson type IIa lipidaemia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>familial hyperbetalipoproteinaemia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>familial hypercholesteremia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hyperbetalipoproteinemia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hyperlipoproteinemia type II</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>type II hyperlipidemia</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005439</oboInOwl:id>
        <rdfs:comment>Editor note: TODO check xrefs</rdfs:comment>
        <rdfs:label>familial hypercholesterolemia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005550 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005550">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0100336"/>
        <obo:IAO_0000115>A disorder directly resulting from the presence and activity of a microbial, viral, or parasitic agent in humans. It can be transmitted by direct or indirect contact.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0050117</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0005741</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:A00-B99</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:079.0</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:136.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:136.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>IDO:0000436</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D003141</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C26726</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:40733004</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>communicable disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>infection</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>infectious</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>infectious disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>infectious diseases and manifestations</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>infectious disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>transmissible disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>clinical infection</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasRelatedSynonym>disease by infectious agent</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005550</oboInOwl:id>
        <rdfs:comment>Replaces &apos;infection&apos; in disease hierarchy. OBI imported term infection is moved to pathologic process. This class is a container class for infectious diseases, not the process of infection itself.</rdfs:comment>
        <rdfs:label>infectious disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005552 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005552">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005328"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005385"/>
        <obo:IAO_0000115>A disorder that is caused by pathologic changes in the ocular vasculature.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>EFO:0005753</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C35664</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of vasculature of eye</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of vasculature of eye</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of vasculature of eye</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ocular vascular disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>vasculature of eye disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>vasculature of eye disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0005552</oboInOwl:id>
        <rdfs:label>ocular vascular disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005554 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005554">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003900"/>
        <obo:IAO_0000115>Inflammatory and degenerative diseases of connective tissue structures, such as arthritis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:1575</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0005755</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:729.0</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D012216</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C27204</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:396332003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0035435</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Wikipedia:Rheumatism</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>rheumatic disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>rheumatologic disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>collagen disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>collagen vascular disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>connective tissue disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>disease, rheumatic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>diseases, rheumatic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>enthesopathies</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>enthesopathy</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>inflammatory rheumatism</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>musculoskeletal pain disorder</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>rheumatism</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005554</oboInOwl:id>
        <rdfs:comment>This is an umbrella term encompassing conditions causing chronic, often intermittent pain affecting the joints and/or connective tissue</rdfs:comment>
        <rdfs:label>rheumatic disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005557 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005557">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0000226"/>
        <obo:IAO_0000115>Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:10575</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0005769</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:275.4</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:275.40</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:275.49</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D002128</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:71638002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0006705</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disorder of calcium metabolism</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>calcium metabolism disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>calcium metabolism disorder</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0005557</oboInOwl:id>
        <rdfs:comment>Defined in terms of GO calcium ion homeostatis. Also consistent with HPO. Note advice from GO as calcium ions are neither created or destroyed is not metabolic process in terms of go, but name retained for purposes of consistency with e.g. Snomed and Mesh, Consider relocating this as a sibling of metabolic disease.</rdfs:comment>
        <rdfs:label>calcium metabolic disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005560 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005560">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002602"/>
        <obo:IAO_0000115>A disease affecting the brain or part of the brain.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:936</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0005774</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:348.3</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:348.30</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:348.8</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:348.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D001927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C96413</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:81308009</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0006111</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0085584</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>brain disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>brain disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of brain</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of brain</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of brain</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>encephalopathy</oboInOwl:hasNarrowSynonym>
        <oboInOwl:id>MONDO:0005560</oboInOwl:id>
        <rdfs:comment>Editor note: NCIT has different classes for brain disease and encephalopathy</rdfs:comment>
        <rdfs:label>brain disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0005578 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0005578">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002614"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0006816"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0021166"/>
        <obo:IAO_0000115>An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:848</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:0005856</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D001168</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C2883</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:3723001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0003864</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Wikipedia:Arthritis</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>arthritis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inflammation of skeletal joint</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>skeletal joint inflammation</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>inflammatory disorder of joint</oboInOwl:hasNarrowSynonym>
        <oboInOwl:id>MONDO:0005578</oboInOwl:id>
        <rdfs:comment>Editor note: osteoarthritis is primarily non-inflammatory which causes issues if we classify arthritis as inflammatory.</rdfs:comment>
        <rdfs:label>arthritic joint disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0006496 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0006496">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002602"/>
        <obo:IAO_0000115>A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>EFO:1000631</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:G80-G83</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D010243</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Wikipedia:Palsy</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Plegia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Plegias</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0006496</oboInOwl:id>
        <rdfs:label>palsy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0006504 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0006504">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005066"/>
        <obo:IAO_0000115>An instance of metabolic disease that is acquired during the lifetime of the individual.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0060158</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:1000639</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>acquired metabolic disease</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0006504</oboInOwl:id>
        <rdfs:label>acquired metabolic disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0006559 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0006559">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002260"/>
        <obo:IAO_0000115>A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:2280</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:1000710</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>GARD:0006658</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:L73.2</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D017497</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:387</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:59393003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0162836</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Wikipedia:Hidradenitis_suppurativa</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>acne inversa</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ectopic acne</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>fox den disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hidradenitis suppurativa</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>pyoderma fistulans significa</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>verneuil disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>acne inversa, familial</oboInOwl:hasNarrowSynonym>
        <oboInOwl:id>MONDO:0006559</oboInOwl:id>
        <rdfs:label>hidradenitis suppurativa</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0006615 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0006615">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005093"/>
        <obo:IAO_0000115>A disease involving the sweat gland.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:1383</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:1000772</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:705</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:705.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:705.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D013543</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:88232005</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0038986</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of sweat gland</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of sweat gland</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of sweat gland</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>sweat gland disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>sweat gland disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>disease of sweat glands</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>disorder of sweat glands</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0006615</oboInOwl:id>
        <rdfs:label>sweat gland disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0006816 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0006816">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005172"/>
        <obo:IAO_0000115>Any disorder of the joints.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:381</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:1000999</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:711</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:716.80</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:716.88</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:716.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:716.90</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:716.98</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:719.80</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:719.88</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:719.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:719.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:719.90</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:719.98</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D007592</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10003285</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C35760</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:399269003</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0022408</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Joint ankylosis of the ankle and/or foot</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Joint disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ankylosis of joint of ankle and/or foot</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ankylosis of joint of forearm</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ankylosis of joint of hand</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ankylosis of joint of lower leg</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ankylosis of joint of upper arm</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>arthropathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of skeletal joint</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of skeletal joint</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of skeletal joint</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder, Joint</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>skeletal joint disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>skeletal joint disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>Joint ankylosis of the ankle and foot</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Joint ankylosis of the forearm</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Joint ankylosis of the hand</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Joint ankylosis of the lower leg</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Joint ankylosis of the pelvic region and thigh</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Joint ankylosis of the shoulder region</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Joint ankylosis of the upper arm</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>ankylosis of ankle and foot joint</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>ankylosis of forearm joint</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>ankylosis of hand joint</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>ankylosis of joint of multiple sites</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>ankylosis of joint of pelvic region and thigh</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>ankylosis of joint of shoulder region</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>ankylosis of lower leg joint</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>ankylosis of multiple joints</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>ankylosis of upper arm joint</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>infectious arthropathy</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasRelatedSynonym>arthrosis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>disorder of joint</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>joint disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>joint disorder</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0006816</oboInOwl:id>
        <rdfs:label>arthropathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0006923 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0006923">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0021679"/>
        <obo:IAO_0000115>Infections with bacteria of the family bacillaceae.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>EFO:1001124</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D016863</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0085389</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Bacillaceae caused disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Bacillaceae disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>Bacillaceae infection</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>infection, Bacillaceae</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>infections, Bacillaceae</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0006923</oboInOwl:id>
        <rdfs:label>Bacillaceae infectious disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0007344 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0007344">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003847"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0043537"/>
        <obo:IAO_0000115>An instance of cluster headache syndrome that is caused by an inherited modification of the individual&apos;s genome.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>MESH:C566117</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>OMIM:119915</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C1861513</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>cluster headache, familial</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hereditary cluster headache syndrome</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0007344</oboInOwl:id>
        <rdfs:label>cluster headache, familial</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0007728 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0007728">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0024516"/>
        <obo:IAO_0000115>Any familial acne inversa in which the cause of the disease is a mutation in the NCSTN gene.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>OMIM:142690</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN028850</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>NCSTN familial acne inversa</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>acne inversa, familial, 1</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>acne inversa, familial, type 1</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>familial acne inversa caused by mutation in NCSTN</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>ACNINV1</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>acne inversa, familial</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>hidradenitis suppurativa, familial</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0007728</oboInOwl:id>
        <rdfs:label>acne inversa, familial, 1</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0009453 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0009453">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003847"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005046"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>MESH:C565469</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>OMIM:242850</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C1855771</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>immune deficiency disease</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0009453</oboInOwl:id>
        <rdfs:label>immune deficiency disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0011429 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0011429">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005554"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005578"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700007"/>
        <obo:IAO_0000115>Juvenile idiopathic arthritis (JIA) is the term used to describe a group of inflammatory articular disorders of unknown cause that begin before the age of 16 and last over 6 weeks. The term juvenile idiopathic arthritis was chosen to signify the absence of any known mechanism underlying the disorder and to highlight the necessity of excluding other types of arthritis occurring in well defined diseases (in particular arthritis occurring in association with infectious, inflammatory and haematooncologic diseases).</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/4521</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:676</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:M08.4</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:714.3</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:714.31</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:714.32</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:714.33</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D001171</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10059177</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C114357</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C26979</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>OMIM:604302</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:92</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:410502007</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:74391003</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>JIA</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Juvenile idiopathic arthritis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>juvenile idiopathic arthritis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>juvenile rheumatoid arthritis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>rheumatoid arthritis, systemic juvenile, susceptibility to</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>acute juvenile rheumatoid arthritis</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>monarticular juvenile rheumatoid arthritis</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>pauciarticular juvenile arthritis</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>pauciarticular onset juvenile chronic arthritis</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>systemic juvenile rheumatoid arthritis</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasRelatedSynonym>juvenile chronic arthritis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>juvenile chronic polyarthritis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>rheumatoid arthritis, systemic juvenile</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0011429</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>juvenile idiopathic arthritis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0013021 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0013021">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0015135"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0017954"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0023603"/>
        <obo:IAO_0000115>An autoinflammatory disease caused by mutations in the IL1RN gene, which encodes the IL1 receptor antagonist. It presents in infancy, and is characterized by systemic inflammation, pustular rash, bone pain, sterile osteitis, and periostitis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>GARD:0010516</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:C557815</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C119056</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>OMIM:612852</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:210115</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C2748507</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>DIRA</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Interleukin-1 receptor antagonist deficiency</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>OMPP</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>autoinflammatory disease due to interleukin-1 receptor antagonist deficiency</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>deficiency of the Interleukin-1 receptor antagonist</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>Interleukin 1 receptor antagonist deficiency</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>deficiency of interleukin-1 receptor antagonist</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>osteomyelitis, STERILE multifocal, with periostitis and pustulosis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0013021</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_disease"/>
        <rdfs:label>sterile multifocal osteomyelitis with periostitis and pustulosis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0013397 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0013397">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0024516"/>
        <obo:IAO_0000115>Any familial acne inversa in which the cause of the disease is a mutation in the PSENEN gene.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>OMIM:613736</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C3151037</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>PSENEN familial acne inversa</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>acne inversa, familial, 2</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>acne inversa, familial, type 2</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>familial acne inversa caused by mutation in PSENEN</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>ACNINV2</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>acne inversa, familial, 2, with or without Dowling-Degos disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0013397</oboInOwl:id>
        <rdfs:label>acne inversa, familial, 2</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0013398 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0013398">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0024516"/>
        <obo:IAO_0000115>Any familial acne inversa in which the cause of the disease is a mutation in the PSEN1 gene.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>OMIM:613737</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C3151038</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>PSEN1 familial acne inversa</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>acne inversa, familial, 3</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>acne inversa, familial, type 3</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>familial acne inversa caused by mutation in PSEN1</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>ACNINV3</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0013398</oboInOwl:id>
        <rdfs:label>acne inversa, familial, 3</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0015135 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0015135">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003778"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>Orphanet:101988</oboInOwl:hasDbXref>
        <oboInOwl:hasRelatedSynonym>primary immunodeficiency due to a defect in innate immunity</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0015135</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>primary immunodeficiency due to a genetic defect in innate immunity</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0015530 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0015530">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003543"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0017181"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0043218"/>
        <obo:IAO_0000115>A headache disorder characterized by episodes of unilateral, short lasting pain and associated ipsilateral cranial autonomic symptoms.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>ICD9:339.09</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D051303</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C117074</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:157843</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:449814007</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C1565172</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0015530</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>trigeminal autonomic cephalalgia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0015923 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0015923">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005244"/>
        <obo:IAO_0000115>An instance of peripheral neuropathy that is acquired during the lifetime of the individual.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>Orphanet:182086</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>acquired peripheral neuropathy</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0015923</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>acquired peripheral neuropathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0016179 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0016179">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0015923"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>Orphanet:209013</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0016179</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>acquired amyloid peripheral neuropathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0016330 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0016330">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005045"/>
        <obo:IAO_0000115>An instance of hypertrophic cardiomyopathy that is acquired during the lifetime of the individual.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>Orphanet:217598</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN226903</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>acquired hypertrophic cardiomyopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0016330</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>non-familial hypertrophic cardiomyopathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0016345 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0016345">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005201"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>EFO:1001473</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:217720</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN226908</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0016345</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>non-familial restrictive cardiomyopathy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0016595 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0016595">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005119"/>
        <obo:IAO_0000115>A rare acute systemic infection caused by the inhalation of Bacillus anthracis spores (e.g. through infected animal products, bioterrorism) and characterized by an initial stage where patients present with non specific symptoms (fever, cough, chills, fatigue) that is followed by an acute phase during which hemorrhagic mediastinitis occurs that can progress into meningitis, gastrointestinal involvement, and refractory shock, that can be fatal, if left untreated.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0050160</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:022.1</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:C571912</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10035667</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:247257</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:11389007</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0155866</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>inhalation anthrax disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>pulmonary anthrax</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>respiratory anthrax</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>respiratory anthrax disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>wool-sorters&apos; disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>woolsorters&apos; disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>inhalation anthrax</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0016595</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_disease"/>
        <rdfs:label>inhalational anthrax</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0016617 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0016617">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0019432"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>Orphanet:247854</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>juvenile rheumatoid factor-negative polyarthritis with anti-nuclear antibodies</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>polyarthritis without rheumatoid factor with anti-nuclear antibodies</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>rheumatoid factor-negative JIA with anti-nuclear antibodies</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0016617</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_etiological_subtype"/>
        <rdfs:label>rheumatoid factor-negative juvenile idiopathic arthritis with anti-nuclear antibodies</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0016618 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0016618">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0019432"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>Orphanet:247861</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>juvenile rheumatoid factor-negative polyarthritis without anti-nuclear antibodies</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>polyarthritis without rheumatoid factor without anti-nuclear antibodies</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>rheumatoid factor-negative JIA without anti-nuclear antibodies</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0016618</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_etiological_subtype"/>
        <rdfs:label>rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0017181 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0017181">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0021146"/>
        <obo:IAO_0000115>Conditions in which the primary symptom is headache and the headache cannot be attributed to any known causes.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <obo:IAO_0000589>hypnic headache (disease)</obo:IAO_0000589>
        <oboInOwl:hasDbXref>GARD:0010796</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>HP:0012459</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:339.81</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D051270</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:276429</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:122711000119109</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>hypnic headache</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hypnic headache (disease)</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0017181</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_disease"/>
        <rdfs:label>hypnic headache</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0017816 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0017816">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0019438"/>
        <obo:IAO_0000115>Primary systemic amyloidosis (PSA) is a form of AL amyloidosis caused by the aggregation and deposition of insoluble amyloid fibrils derived from misfolded monoclonal immunoglobulin light chains usually produced by a plasma cell tumor and characterized by multiple organ involvement.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>NCIT:C8299</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:314701</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:89449005</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0268380</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0281479</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>systemic AL amyloidosis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>systemic Immunoglobulin Light chain amyloidosis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>systemic amyloidosis</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0017816</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_clinical_subtype"/>
        <rdfs:label>primary systemic amyloidosis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0017817 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0017817">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0019438"/>
        <obo:IAO_0000115>Primary localized amyloidosis is a form of AL amyloidosis caused by the aggregation of insoluble amyloid fibrils derived from misfolded monoclonal immunoglobulin light chains usually produced by a plasma cell tumor and characterized by localized amyloid deposition with clinical manifestations restricted to the organ involved, most frequently urinary tract (bladder), eye, respiratory tract (larynx, lungs), and skin.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>Orphanet:314709</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>localized AL amyloidosis</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0017817</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_clinical_subtype"/>
        <rdfs:label>primary localized amyloidosis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0017954 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0017954">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0019751"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>Orphanet:324927</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN204100</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0017954</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>pyogenic autoinflammatory syndrome</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0018124 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0018124">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0001068"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005151"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0021073"/>
        <obo:IAO_0000115>Oncogenic osteomalacia is characterized by the development of a tumor that causes the bones to be weakened. This occurs when a tumor secretes a substance called fibroblast growth factor 23 (FGF23). FGF23 inhibits the ability of the kidneys to absorb phosphate. Phosphate is important for keeping bones strong and healthy. Therefore, this disease is characterized by a softening and weakening of the bones (osteomalacia). The disease also results in multiple biochemical abnormalities including high levels of phosphate in the urine (hyperphosphaturia) and low levels of phosphate in the blood (hypophosphatemia). The majority of tumors that cause oncogenic osteomalacia are small and slow-growing. These tumors most commonly occur in the skin, muscles, or bones of the extremities or in the paranasal sinuses around the head. Most of these tumors are benign, meaning they are not associated with cancer. The exact reason that the tumors associated with oncogenic osteomalacia develop is not known. The disease is diagnosed when a person experiences clinical features such as bone weakening and hyperphosphaturia and a tumor is found by imaging of the body. Treatment of the disease consists of surgical removal of the tumor. The symptoms of the disease, including the weakening of the bones, typically resolve once the tumor is removed.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>GARD:0009652</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:C537751</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C67235</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:352540</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:392559009</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C1274103</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Oncogenic hypophosphatemic osteomalacia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>TIO</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>tumor-induced osteomalacia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>OO</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>OOM</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0018124</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#gard_rare"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_disease"/>
        <rdfs:label>Oncogenic osteomalacia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0018328 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0018328">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005439"/>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/5537</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>MESH:D000090542</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:391665</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:238078005</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>HoFH</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>homozygous familial hypercholesterolemia</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0018328</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_disease"/>
        <rdfs:label>homozygous familial hypercholesterolemia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0018456 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0018456">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0011429"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>EFO:1002020</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:404580</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:16044751000119106</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>juvenile polyarthritis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>juvenile polyarticular arthritis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>polyarticular JIA</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0018456</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>polyarticular juvenile idiopathic arthritis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0019052 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0019052">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003847"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005066"/>
        <obo:IAO_0000115>An inherited disorder resulting from an enzyme defect in biochemical and metabolic pathways affecting proteins, fats, carbohydrates metabolism or organelle function.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/1483</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:655</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D008661</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10058097</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10062018</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C34816</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:68367</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:86095007</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0025521</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>congenital metabolic disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>congenital metabolism disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hereditary metabolic disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inborn disorders of metabolism</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inborn error of metabolism</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inborn errors of metabolism</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inborn metabolic disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inborn metabolism disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inherited disorder of metabolism</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inherited disorders of metabolism</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inherited metabolic disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>metabolic hereditary disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>rare inborn errors of metabolism</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>rare inherited metabolic disorder</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasRelatedSynonym>rare metabolic disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0019052</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:comment>Note that the ordo class is specifically for rare diseases, but we broaden to be inclusive of HH1</rdfs:comment>
        <rdfs:label>inborn errors of metabolism</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0019056 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0019056">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005071"/>
        <obo:IAO_0000115>Any disease that impairs the functioning of the muscles, either directly, being pathologies of the voluntary muscle, or indirectly, being pathologies of nerves or neuromuscular junctions</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:440</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:1001902</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:358</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:358.9</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D009468</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10029323</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:68381</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0027868</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>nerve and muscle disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>neuromuscular disease</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0019056</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>neuromuscular disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0019065 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0019065">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0021179"/>
        <obo:IAO_0000115>A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <obo:IAO_0000589>amyloidosis (disease)</obo:IAO_0000589>
        <oboInOwl:hasDbXref>DOID:9120</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>EFO:1001875</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>HP:0011034</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:277.3</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:277.30</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D000686</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10002022</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C2868</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ONCOTREE:MIDDA</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:69</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:17602002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0002726</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>amyloid</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>amyloid disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>amyloidoses</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>amyloidosis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>amyloidosis (disease)</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0019065</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>amyloidosis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0019432 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0019432">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0018456"/>
        <obo:IAO_0000115>Rheumatoid factor-negative polyarthritis is a term used to describe a group of poorly defined heterogenous conditions that incorporates forms of rheumatoid factor-negative polyarthritis and forms of oligoarticular arthritis that become extensive in less than 6 months after onset.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>Orphanet:85408</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>juvenile rheumatoid factor-negative polyarthritis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>polyarthritis without rheumatoid factor</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>rheumatoid factor-negative JIA</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0019432</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_disease"/>
        <rdfs:label>rheumatoid factor-negative juvenile idiopathic arthritis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0019435 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0019435">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0018456"/>
        <obo:IAO_0000115>A category of juvenile idiopathic arthritis defined by the presence of arthritis affecting five or more separate joints during the first six months of disease, with positive serologic testing for rheumatoid factor.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>NCIT:C119034</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:85435</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C3890733</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>juvenile idiopathic rheumatoid factor-positive polyarthritis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>polyarthritis with rheumatoid factor</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>polyarticular JIA, RF+</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>polyarticular juvenile idiopathic arthritis, RF+</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>polyarticular juvenile idiopathic arthritis, rheumatoid Factor Positive</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>rheumatoid factor-positive polyarticular JIA</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0019435</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_disease"/>
        <rdfs:label>rheumatoid factor-positive polyarticular juvenile idiopathic arthritis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0019438 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0019438">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0006504"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0016179"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0016330"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0016345"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0019065"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0019724"/>
        <obo:IAO_0000115>AL Amyloidosis is a plasma cell disorder characterized by the aggregation and deposition of insoluble amyloid fibrils derived from misfolding of monoclonal immunoglobulin light chains usually produced by a plasma cell tumor. It usually presents as primary systemic amyloidosis (PSA) with multiple organ involvement and less frequently as primary localized amyloidosis (PLA) restricted to a single organ.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>DOID:0080933</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>GARD:0005797</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:C531616</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10036673</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C158963</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:85443</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0268381</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Light-chain amyloidosis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>primary amyloidosis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>Light chain amyloidosis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>amyloidosis AL</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>amyloidosis primary systemic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>primary AL amyloidosis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>primary amyloidosis (formerly)</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>primary systemic AL amyloidosis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>primary systemic amyloidosis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>systemic AL amyloidsis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0019438</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#gard_rare"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_disease"/>
        <rdfs:label>AL amyloidosis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0019722 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0019722">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005240"/>
        <obo:IAO_0000115>A disease involving the renal glomerulus.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>GTR:AN0966176</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:N00-N08</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C120887</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:93548</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:197679002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN580795</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of renal glomerulus</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of renal glomerulus</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of renal glomerulus</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>glomerulopathy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>renal glomerulus disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>renal glomerulus disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>glomerulopathies</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0019722</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>glomerular disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0019724 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0019724">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0019722"/>
        <obo:IAO_0000115>Secondary glomerular diseases are conditions with glomerular pathology in which an underlying cause can be established.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>Orphanet:93551</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN206631</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0019724</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:label>secondary glomerular disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0019751 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0019751">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002254"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005554"/>
        <obo:IAO_0000115>A group of disorders of the innate immune system characterized by attacks of seemingly unprovoked inflammation without significant levels of either autoantibodies or autoreactive T cells more characteristic of autoimmune disease.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>ICD10CM:M04-M04</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10072220</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C119050</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:93665</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C3267073</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C3890737</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0019751</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#ordo_group_of_disorders"/>
        <rdfs:comment>Editor note: todo - investigate diseases that have autoinflammatory and autommune components, e.g. IBD, Ankylosing Spondylitis, Axial Spondyloarthropathy, perhaps adult Onset Still&apos;s Disease. Consider disjointness axiom</rdfs:comment>
        <rdfs:label>autoinflammatory syndrome</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0021073 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0021073">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0002254"/>
        <obo:IAO_0000115>A classification for rare disorders of diverse organ systems (endocrine, neuromuscular, gastrointestinal, renal, dermatologic, rheumatologic, hematologic) that are affected by substances secreted by a distant neoplasm but not by the action of the neoplasm itself metastasizing to that organ or tissue. Less than 1 % of neoplasms are associated with these syndromes. An immune-mediated response to neoplasm-elaborated proteins may be the cause of these syndromes. Additionally, their manifestation may signal the presence of an occult neoplasm, potentially at an earlier stage of disease thereby leading to a better clinical outcome. Constitutional signs may include fever, night sweats, anorexia and cachexia. Clinical course is usually progressive. Prognosis is variable depending on the effective treatment of the underlying neoplasm.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>MESH:D010257</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3311</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:49783001</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0030472</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>paraneoplastic syndrome</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0021073</oboInOwl:id>
        <rdfs:label>paraneoplastic syndrome</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0021146 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0021146">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700057"/>
        <obo:IAO_0000115>Various conditions with the symptom of headache. Headache disorders are classified into major groups, such as primary headache disorders (based on characteristics of their headache symptoms) and secondary headache disorders (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>MESH:D020773</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:230461009</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>headache disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>cephalgia syndrome</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>cephalgia syndromes</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>chronic daily headache</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>chronic daily headaches</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>chronic headache</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>chronic headaches</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>daily headache, chronic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>daily headaches, chronic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache syndrome</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache syndromes</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache, chronic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache, chronic daily</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache, intractable</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headaches, chronic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headaches, chronic daily</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headaches, intractable</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>intractable headache</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>intractable headaches</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndrome, headache</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0021146</oboInOwl:id>
        <rdfs:label>headache disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0021166 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0021166">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease involving a pathogenic inflammatory response in the anatomical structure.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>ICD9:799.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C93210</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:128139000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C1290884</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>anatomical structure inflammation</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inflammation of anatomical structure</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inflammatory disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>inflammatory disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0021166</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#harrisons_view"/>
        <rdfs:label>inflammatory disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0021179 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0021179">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005066"/>
        <obo:IAO_0000115>Disorders caused by imbalances in the protein homeostasis network - synthesis, folding, and transport of proteins; post-translational modifications; and degradation or clearance of misfolded proteins.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>MESH:D057165</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C2718000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C2718001</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Proteostasis deficiency</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Proteostasis dysfunction</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Proteostasis dysfunctions</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>deficiencies, Proteostasis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>deficiency, Proteostasis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>dysfunction, Proteostasis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>dysfunctions, Proteostasis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasNarrowSynonym>Misfolding disease, Protein</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Misfolding diseases, Protein</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Misfolding disorder, Protein</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Misfolding disorders, Protein</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Protein Misfolding disease</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Protein Misfolding diseases</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Protein Misfolding disorder</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Protein Misfolding disorders</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Protein folding disease</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Protein folding diseases</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Protein folding disorder</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>Protein folding disorders</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>disease, Protein Misfolding</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>disease, Protein folding</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>diseases, Protein Misfolding</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>diseases, Protein folding</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>disorder, Protein Misfolding</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>disorder, Protein folding</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>disorders, Protein Misfolding</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>disorders, Protein folding</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>folding disease, Protein</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>folding diseases, Protein</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>folding disorder, Protein</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasNarrowSynonym>folding disorders, Protein</oboInOwl:hasNarrowSynonym>
        <oboInOwl:hasRelatedSynonym>proteinopathy</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>proteopathic disease</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>proteopathy</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0021179</oboInOwl:id>
        <rdfs:label>proteostasis deficiencies</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0021187 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0021187">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005066"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <obo:IAO_0000589>hyperlipidemia (disease)</obo:IAO_0000589>
        <oboInOwl:hasDbXref>EFO:0003774</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>HP:0003077</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD10CM:E78.5</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:272.4</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D006949</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:55822004</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0020473</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:CN236649</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>hyperlipidemia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hyperlipidemia (disease)</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>hyperlipemia</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>hyperlipemias</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>lipemia</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>lipemias</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>lipidemia</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>lipidemias</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0021187</oboInOwl:id>
        <rdfs:label>hyperlipidemia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0021679 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0021679">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005113"/>
        <obo:IAO_0000115>Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>ICD9:041.89</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D016908</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:371582002</oboInOwl:hasDbXref>
        <oboInOwl:hasRelatedSynonym>Gram Positive bacterial infections</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>Gram-positive bacterial infection</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>bacterial infection, Gram-positive</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>bacterial infections, Gram Positive</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>bacterial infections, Gram-positive</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>infection, Gram-positive bacterial</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>infections, Gram Positive bacterial</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>infections, Gram-positive bacterial</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0021679</oboInOwl:id>
        <rdfs:comment>Editor note: this does not correspond to a taxonomic grouping, so classification is manual for now</rdfs:comment>
        <rdfs:label>gram-positive bacterial infections</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0022205 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0022205">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005083"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>GARD:0012813</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>ICD9:696.1</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MEDGEN:508876</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:200973000</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0152081</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>pustular psoriasis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>Pustular psoriasis</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0022205</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#gard_rare"/>
        <rdfs:label>pustular psoriasis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0023603 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0023603">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003847"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003900"/>
        <obo:IAO_0000115>An inherited genetic disorder that affects the connective tissues. Representative examples include Ehlers-Danlos syndrome and Marfan syndrome.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/3606</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>NCIT:C97075</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:363045008</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0410787</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Mendelian connective tissue disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>connective tissue hereditary disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hereditary connective tissue disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>Hereditary Connective Tissue Disorder</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>Inherited disorder of connective tissue</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>inherited disorder of connective tissue</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0023603</oboInOwl:id>
        <rdfs:label>hereditary disorder of connective tissue</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0024458 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0024458">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease that involves the visual system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>SCTID:128127008</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of visual system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of visual system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of visual system</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>visual system disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>visual system disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>visual system disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0024458</oboInOwl:id>
        <rdfs:label>disorder of visual system</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0024467 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0024467">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0006615"/>
        <obo:IAO_0000115>A disease that involves the apocrine sweat gland.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>ICD10CM:L75</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>apocrine sweat gland disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>apocrine sweat gland disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease of apocrine sweat gland</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disease or disorder of apocrine sweat gland</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>disorder of apocrine sweat gland</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0024467</oboInOwl:id>
        <rdfs:label>apocrine sweat gland disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0024516 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0024516">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0006559"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0100118"/>
        <obo:IAO_0000115>An instance of hidradenitis suppurativa that is caused by an inherited modification of the individual&apos;s genome.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>OMIMPS:142690</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>ACNINV</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>familial hidradenitis suppurativa</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hereditary hidradenitis suppurativa</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0024516</oboInOwl:id>
        <rdfs:label>familial acne inversa</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0026045 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0026045">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005093"/>
        <obo:IAO_0000115>Prurigonodularis (PN) is a skin disease in which hard crusty lumps are formed on the skin that itches intensely. Repetitive rubbing, scratching, and touching results in more lesions in the skin. The itching is so intense that people scratch themselves to the point of bleeding or pain. The lumps formed in the skin are hard, and have about a half inch across, with a dry and rough top that is often scratched open. They tend to be located in the areas most easily reached and are worse on the outer sides: arms, shoulders and legs. The trunk, face and even palms can also be affected. The exact cause is unknown but some factors triggering PN include liver and kidneys problems, nervous and mental conditions and other skin diseases. Prurigo nodulares, in some cases, can be seen in other diseases such as lymphoma, chronic autoimmune cholestatic hepatitis, HIV infection, severe anemia,or a chronic kidney disease-related itching known as uremic pruritus. Treatment is very difficult, and may include corticoids, antihistaminic and other medication such as thalidomide and similar (Lenalidomide). In some cases, cryotherapy, photochemotherapy and habit reversal therapy for the itch-scratch cycle has improved the symptoms. PN can last for many years, and the itching is so intense that may affect all the everyday activities.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>GARD:0007480</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0026045</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#gard_rare"/>
        <rdfs:label>prurigo nodularis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0037748 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0037748">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005066"/>
        <obo:IAO_0000115>An elevated concentration of lipoproteins.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>HP:0010980</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D006951</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C34709</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0020476</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>hyperlipoproteinemia</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0037748</oboInOwl:id>
        <rdfs:label>hyperlipoproteinemia</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0043218 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0043218">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005071"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005385"/>
        <obo:IAO_0000115>A disorder of the nervous system related to a vascular etiology.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>NCIT:C117007</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C3898144</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease of nervous system vasculature</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>nervous system disorder of vasculature</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>neurovascular disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>vasculature nervous system disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0043218</oboInOwl:id>
        <rdfs:label>neurovascular disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0043455 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0043455">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0001566"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0021073"/>
        <obo:IAO_0000115>Hypercalcemia generally develops as a late complication of malignancy; its appearance has grave prognostic significance. It remains unclear, however, whether death is associated with hypercalcemic crisis (uncontrolled or recurrent progressive hypercalcemia) or with advanced disease. Symptoms include central nervous system impairment such as delirium with prominent symptoms of personality change, cognitive dysfunction, disorientation, incoherent speech, and psychotic symptoms such as hallucinations and delusions, smooth muscle hypotonicity, and altered cardiovascular function.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>MESH:C562390</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C3496</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:47709007</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0149911</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>humoral hypercalcemia of malignancy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>hypercalcemia of malignancy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>hhm</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>mahc</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>malignancy associated hypercalcemia</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>malignant hypercalcemia</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0043455</oboInOwl:id>
        <rdfs:label>humoral hypercalcemia of malignancy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0043537 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0043537">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005560"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0015530"/>
        <obo:IAO_0000115>A headache disorder that is characterized by periodic severe, unilateral orbital, supraorbital, and/or temporal pain, and is associated with ipsilateral cranial autonomic symptoms.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>EFO:0008571</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MESH:D003027</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>NCIT:C117077</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>Orphanet:1002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:193031009</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Cephalgia, histamine</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Cephalgias, histamine</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Horton headache</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Horton syndrome</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Horton&apos;s headache</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Horton&apos;s neuralgia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Horton&apos;s syndrome</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Hortons syndrome</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ciliary neuralgia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ciliary neuralgias</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cluster headache</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cluster headache syndrome</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>cluster migraine</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>erythromelalgia of the head</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>erythroprosopalgia of bing</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>histamine cephalgia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>histamine cephalgias</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>histamine headache</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>migraine, neuralgic</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>migraines, neuralgic</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>migrainous neuralgia</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>red migraine</oboInOwl:hasExactSynonym>
        <oboInOwl:hasRelatedSynonym>atypical cluster headache</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>atypical cluster headaches</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>beuralgias, ciliary</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>chronic cluster headache</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>chronic cluster headaches</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>cluster headache syndromes</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>cluster headache, atypical</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>cluster headache, chronic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>cluster headache, episodic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>cluster headaches</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>cluster headaches, atypical</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>cluster headaches, chronic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>cluster headaches, episodic</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>episodic cluster headache</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>episodic cluster headaches</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache syndrome, cluster</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache syndromes, cluster</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache, atypical cluster</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache, chronic cluster</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache, cluster</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headache, episodic cluster</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headaches, atypical cluster</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headaches, chronic cluster</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headaches, cluster</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>headaches, episodic cluster</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>neuralgia, ciliary</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>neuralgic migraine</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>neuralgic migraines</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndrome, Horton</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndrome, Horton&apos;s</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndrome, cluster headache</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>syndromes, cluster headache</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym>vasomotor headache</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id>MONDO:0043537</oboInOwl:id>
        <rdfs:label>cluster headache syndrome</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0100118 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0100118">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0003847"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005093"/>
        <obo:IAO_0000115>An instance of skin disease that is caused by a modification of the individual&apos;s genome.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/5682</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>MESH:D012873</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:239001006</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>disease, genetic skin</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>diseases, genetic skin</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>genetic skin disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>genetic skin diseases</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>genodermatosis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>skin disease, genetic</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0100118</oboInOwl:id>
        <rdfs:label>genetic skin disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0100336 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0100336">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease or disorder that result from the presence and activity of a microbial, viral, fungal or parasitic agent, or a disorder that follows infection with an infectious agent but is distinct from the usual manifestations of the infection itself.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/5861</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasExactSynonym>infectious disease or sequela</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0100336</oboInOwl:id>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#disease_grouping"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#harrisons_view"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/mondo#obsoletion_candidate"/>
        <rdfs:comment>Reason of obsoletion: out of scope - MONDO:excludeGroupingClass. Term to consider: post-infectious immune dysfunction disease.</rdfs:comment>
        <rdfs:label>infectious disease or post-infectious disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0100491 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0100491">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0022205"/>
        <obo:IAO_0000115>A rare and extreme form of psoriasis characterized by the appearance of sterile pustules which can take many patterns. All the main pathological features of the disease are accentuated. Generalized pustular psoriasis is clinically heterogeneous in its age at onset, precipitants, severity, and natural history. Many overlapping clinical entities are recognized. There is a relationship between these entities and plaque psoriasis, as some individuals may have episodes of plaque psoriasis preceding or following the generalized pustular psoriasis, but in others generalized pustular psoriasis occurs as the sole phenotype without plaque psoriasis at any time.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/4496</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasDbXref>ICD10CM:L40.1</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SCTID:238612002</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>UMLS:C0343055</oboInOwl:hasDbXref>
        <oboInOwl:id>MONDO:0100491</oboInOwl:id>
        <rdfs:label>generalized pustular psoriasis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0700007 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0700007">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0700096"/>
        <obo:IAO_0000115>A disease or disorder for which the cause is of uncertain or unknown.</obo:IAO_0000115>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/3169</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasExactSynonym>idiopathic disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0700007</oboInOwl:id>
        <rdfs:label>idiopathic disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0700057 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0700057">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0005071"/>
        <obo:IAO_0000115>A nervous system disorder that has pain as a major feature.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasExactSynonym>neurologic pain syndrome</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>neurological pain disease</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0700057</oboInOwl:id>
        <rdfs:label>neurological pain disorder</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/MONDO_0700096 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/MONDO_0700096">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/MONDO_0000001"/>
        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://github.com/monarch-initiative/mondo/issues/5858</obo:IAO_0000233>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/mondo.owl"/>
        <oboInOwl:hasExactSynonym>human disease or disorder</oboInOwl:hasExactSynonym>
        <oboInOwl:id>MONDO:0700096</oboInOwl:id>
        <rdfs:label>human disease</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C103194 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C103194">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C128057"/>
        <obo:IAO_0000115>A monoclonal antibody directed against B7H1 (B7 homolog 1; programmed cell death ligand 1) with potential immunostimulating activity. Upon intravenous administration, durvalumab binds to the cell surface antigen B7H1, thereby blocking B7H1 signaling. This may activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against B7H1-expressing tumor cells. B7H1, a member of the B7 protein superfamily and a negative regulator of cytokine synthesis, is overexpressed on certain tumor cell types.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Durvalumab</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C106250 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C106250">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C128057"/>
        <obo:IAO_0000115>A humanized, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. Atezolizumab binds to PD-L1, blocking its binding to and activation of its receptor programmed death 1 (PD-1; PDCD1) expressed on activated T-cells, which may enhance the T-cell-mediated immune response to neoplasms and reverse T-cell inactivation. In addition, by binding to PD-L1, atezolizumab also prevents binding of this ligand to B7.1 (CD80) expressed on activated T cells, which further enhances the T-cell-mediated immune response. PD-L1 is overexpressed on many human cancer cell types and on various tumor-infiltrating immune cells. PD-L1 binding to PD-1 on T-cells suppresses the immune system and results in increased immune evasion. PD-1, a transmembrane protein, is a negative regulator of the immune system that limits the expansion and survival of CD8+ T cells. The Fc region of atezolizumab is modified in such a way that it does not induce either antibody-dependent cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Atezolizumab</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C106432 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C106432">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C128037"/>
        <obo:IAO_0000115>A humanized monoclonal immunoglobulin (Ig) G4 antibody directed against human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1) with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, pembrolizumab binds to PD-1, an inhibitory signaling receptor expressed on the surface of activated T cells, and blocks the binding to and activation of PD-1 by its ligands, which results in the activation of T-cell-mediated immune responses against tumor cells. The ligands for PD-1 include programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on APCs. Activated PD-1 negatively regulates T-cell activation and plays a key role in in tumor evasion from host immunity.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Pembrolizumab</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1094 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1094">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1556"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2150"/>
        <obo:IAO_0000115>A fluorinated nucleotide antimetabolite analog of the antiviral agent vidarabine (ara-A) with antineoplastic activity. Administered parenterally as a phosphate salt, fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite may inhibit DNA polymerase alpha, ribonucleotide reductase and DNA primase, thereby interrupting DNA synthesis and inhibiting tumor cell growth.  (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Fludarabine</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C11197 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C11197">
        <obo:IAO_0000115>One of several chemotherapy regimens that include leucovorin calcium (calcium folinate), 5-fluorouracil and oxaliplatin and which may be used in the treatment of advanced-stage and metastatic colorectal cancer. FOLFOX regimens differ in agent dosing and administration schedule and include FOLFOX 4, FOLFOX 6, modified FOLFOX 6 (mFOLFOX 6) and FOLFOX 7.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C11197</obo:NCIT_NHC0>
        <obo:NCIT_P106>Therapeutic or Preventive Procedure</obo:NCIT_P106>
        <obo:NCIT_P107>FOLFOX Regimen</obo:NCIT_P107>
        <obo:NCIT_P108>FOLFOX Regimen</obo:NCIT_P108>
        <obo:NCIT_P207>C0915342</obo:NCIT_P207>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>SEER</obo:NCIT_P322>
        <obo:NCIT_P325>An abbreviation for a chemotherapy combination used to treat colorectal cancer that is advanced or has come back. It is also being studied in the treatment of other types of cancer. It includes the drugs leucovorin calcium (folinic acid), fluorouracil, and oxaliplatin. FOLFOX-4, FOLFOX-6, modified FOLFOX-6 (mFOLFOX-6), and FOLFOX-7 are different in the doses of the three drugs and the ways they are given.</obo:NCIT_P325>
        <obo:NCIT_P366>Fluorouracil_Leucovorin-Calcium_Oxaliplatin</obo:NCIT_P366>
        <obo:NCIT_P399>42512</obo:NCIT_P399>
        <obo:NCIT_P98>FDA approved as first line treatment of Advanced Colorectal Cancer</obo:NCIT_P98>
        <oboInOwl:hasExactSynonym>CF/5-FU/L-OHP</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>FOLFOX</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>FOLFOX Regimen</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>FOLFOX regimen</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Fluorouracil/Leucovorin Calcium/Oxaliplatin</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C160950"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C160952"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C167078"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C167080"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C176424"/>
        <rdfs:label>FOLFOX Regimen</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C124946 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C124946">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C143250"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <obo:IAO_0000115>An agent designed to interfere with the activity of programmed cell death protein 1 (PD1). PD1 inhibitors block T-cell apoptosis and act as non-specific activators of the immune system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>PD1 Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C128036 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C128036">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C141144"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20401"/>
        <obo:IAO_0000115>Any monoclonal antigen against the antigen cytotoxic T-lymphocyte associated protein 4 (CTLA-4; CTLA4; CD152).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Anti-CTLA-4 Monoclonal Antibody</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C128037 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C128037">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C124946"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20401"/>
        <obo:IAO_0000115>A monoclonal antibody directed against programmed cell death protein 1 (PD-1; PD1; CD279).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Anti-PD1 Monoclonal Antibody</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C128057 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C128057">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C156893"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20401"/>
        <obo:IAO_0000115>A monoclonal antibody directed against programmed death-ligand 1 (PD-L1; CD274).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Anti-PD-L1 Monoclonal Antibody</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1282 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1282">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1450"/>
        <obo:IAO_0000115>A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Carboplatin</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1283 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1283">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C307"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C308"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Recombinant Cytokine</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C128631 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C128631">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177692"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C74095"/>
        <obo:IAO_0000115>A finding indicating that CD20 is present on cells or expressed by cells.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C128631</obo:NCIT_NHC0>
        <obo:NCIT_P106>Laboratory or Test Result</obo:NCIT_P106>
        <obo:NCIT_P107>CD20 Positive</obo:NCIT_P107>
        <obo:NCIT_P108>CD20 Positive</obo:NCIT_P108>
        <obo:NCIT_P207>C3888518</obo:NCIT_P207>
        <obo:NCIT_P322>CPTAC</obo:NCIT_P322>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <oboInOwl:hasExactSynonym>CD20 Antigen Positive</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CD20 Expressing</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CD20 Positive</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CD20 Present</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CD20+</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Leu-16 Positive</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>MS4A1 Positive</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118168"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142800"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156952"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156953"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159339"/>
        <rdfs:label>CD20 Positive</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C129821 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C129821">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C274"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C307"/>
        <obo:IAO_0000115>Any agent that has a biological nature, such as agents containing living organisms, derived from living organisms, or comprised of ex vivo synthesized analogs of substances derived from living organisms, and that exerts antineoplastic activity.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Antineoplastic Biological Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C129824 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C129824">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2189"/>
        <obo:IAO_0000115>Any agent that inhibits the activity of any protein that is involved in cancer-specific pathways. An antineoplastic protein inhibitor is a specific cancer cell-targeting agent.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Antineoplastic Protein Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C129825 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C129825">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C129824"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C471"/>
        <obo:IAO_0000115>Any agent that specifically inhibits a particular enzyme that is overexpressed and/or mutated in cancer cell pathways. Antineoplastic enzyme inhibitors specifically target tumor cells by targeting enzymes that are not normally expressed or are minimally expressed in normal, healthy tissues.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Antineoplastic Enzyme Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1323 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1323">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C257"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C471"/>
        <obo:IAO_0000115>Any agent that inhibits prostaglandin G/H synthase (cyclooxygenase or COX), an enzyme that catalyzes the production of prostanoids, including prostaglandins, prostacyclin and thromboxane, from arachidonic acid. Cyclooxygenase inhibitors are a type of non-steroidal anti-inflammatory drug.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Cyclooxygenase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1331 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1331">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1931"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1968"/>
        <obo:IAO_0000115>An alkaloid isolated or derived synthetically from Podophyllum peltatum that can bind to and inhibit topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Epipodophyllotoxin Compound</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C136485 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C136485">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27975"/>
        <obo:IAO_0000115>A stage term referring to invasive lung cancer. It includes: T1c, N0, M0. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C136485</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IA3</obo:NCIT_P108>
        <obo:NCIT_P208>CL523788</obo:NCIT_P208>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P375>Stage IA3</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IA3</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IA3</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C137676 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C137676">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27970"/>
        <obo:IAO_0000115>Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites. The definition of stage IIID depends on the particular type of cancer that it refers to; for example, for cutaneous melanoma, stage IIID is defined as follows: T4b, N3a/b/c, M0. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration. N3a: Four or more clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. N3b: Four or more nodal metastases, at least one of which was clinically detected, or presence of any number of matted nodes. Presence of in-transit, satellite, and/or microsatellite metastases: No. N3c: Two or more clinically occult nodal metastases. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. M0: No evidence of distant metastasis. LDH level is not applicable. (partially adapted from AJCC 8th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C137676</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIID</obo:NCIT_P108>
        <obo:NCIT_P207>C3846374</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P375>Stage IIID</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIID</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIID</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C137693 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C137693">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C35681"/>
        <obo:IAO_0000115>Indicates that human immunodeficiency virus has not been detected in a sample.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C137693</obo:NCIT_NHC0>
        <obo:NCIT_P106>Laboratory or Test Result</obo:NCIT_P106>
        <obo:NCIT_P107>Human Immunodeficiency Virus Negative</obo:NCIT_P107>
        <obo:NCIT_P108>Human Immunodeficiency Virus Negative</obo:NCIT_P108>
        <obo:NCIT_P207>C0481430</obo:NCIT_P207>
        <obo:NCIT_P322>CPTAC</obo:NCIT_P322>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <oboInOwl:hasExactSynonym>HIV Negative</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Human Immunodeficiency Virus Negative</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Negative</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118168"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156952"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156953"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157526"/>
        <rdfs:label>Human Immunodeficiency Virus Negative</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C139980 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C139980">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27977"/>
        <obo:IAO_0000115>A stage term that applies to ovarian and fallopian tube carcinoma and indicates that the tumor is limited to ovaries (one or both) or fallopian tube(s) or the tumor involves one or both ovaries or fallopian tubes with pelvic extension below pelvic brim. There are positive retroperitoneal lymph nodes only (histologically confirmed) and no distant metastasis. (adapted from AJCC 8th Ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C139980</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIIA1</obo:NCIT_P108>
        <obo:NCIT_P208>CL538160</obo:NCIT_P208>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P375>Stage IIIA1</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIIA1</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIIA1</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C139981 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C139981">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27977"/>
        <obo:IAO_0000115>A stage term that applies to ovarian and fallopian tube carcinoma and indicates the presence of microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. There is no distant metastasis. (adapted from AJCC 8th Ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C139981</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIIA2</obo:NCIT_P108>
        <obo:NCIT_P208>CL538159</obo:NCIT_P208>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P375>Stage IIIA2</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIIA2</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIIA2</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1404 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1404">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C471"/>
        <obo:IAO_0000115>Any substance that inhibits protein kinase, an enzyme that catalyzes the addition of a phosphate group to a protein and is active in many diverse signaling pathways.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Protein Kinase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1411 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1411">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1490"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C67437"/>
        <obo:IAO_0000115>A compound extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity.  Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division.  This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Paclitaxel</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C141144 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C141144">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C308"/>
        <obo:IAO_0000115>Any agent that modulates the immune checkpoint pathway, either by blocking any inhibitory immune checkpoint protein or by activating any stimulatory immune checkpoint protein.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Immune Checkpoint Modulator</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C141215 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C141215">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C164034"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20401"/>
        <obo:IAO_0000115>Any monoclonal antibody that targets CD20.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Anti-CD20 Monoclonal Antibody</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1413 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1413">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2843"/>
        <obo:IAO_0000115>A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Topotecan inhibits topoisomerase I activity by stabilizing the topoisomerase I-DNA covalent complexes during S phase of cell cycle, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Topotecan</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C141344 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C141344">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27979"/>
        <obo:IAO_0000115>A mycosis fungoides/Sezary syndrome stage defined as follows: T1-4, N0-2, M0, B2. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. T2: Patches, papules, or plaques covering 10% or more of the skin surface. T3: One or more tumors (equal or greater than 1 cm in diameter). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B2: High blood tumor burden: 1,000 per microliter or more Sezary cells with positive clone. (AJCC 8th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C141344</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IVA1</obo:NCIT_P108>
        <obo:NCIT_P207>C3869907</obo:NCIT_P207>
        <oboInOwl:hasExactSynonym>IVA2</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Stage IVA1</oboInOwl:hasExactSynonym>
        <rdfs:label>Stage IVA1</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C141345 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C141345">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27979"/>
        <obo:IAO_0000115>A mycosis fungoides/Sezary syndrome stage defined as follows: T1-4, N3, M0, B0-2. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. T2: Patches, papules, or plaques covering 10% or more of the skin surface. T3: One or more tumors (equal or greater than 1 cm in diameter). T4: Confluence of erythema covering 80% or more of body surface area. N3: Clinically abnormal peripheral lymph nodes; histopathology Dutch grades 3-4 or NCI LN4; clone positive or negative. M0: No visceral organ involvement.  B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. B2: High blood tumor burden: 1,000 per microliter or more Sezary cells with positive clone. (AJCC 8th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C141345</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IVA2</obo:NCIT_P108>
        <obo:NCIT_P207>C3869908</obo:NCIT_P207>
        <oboInOwl:hasExactSynonym>IVA2</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Stage IVA2</oboInOwl:hasExactSynonym>
        <rdfs:label>Stage IVA2</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C14140 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C14140">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28102"/>
        <obo:IAO_0000115>Having a severe and rapid onset of symptoms with short duration.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C14140</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P107>Acute</obo:NCIT_P107>
        <obo:NCIT_P108>Acute</obo:NCIT_P108>
        <obo:NCIT_P207>C0205178</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P325>Morphologic changes that have a rapid onset.</obo:NCIT_P325>
        <obo:NCIT_P325>Symptoms or signs that begin and worsen quickly; not chronic.</obo:NCIT_P325>
        <obo:NCIT_P366>Acute</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>ACUTE</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Acute</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>acute</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C120529"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526"/>
        <rdfs:label>Acute</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C14141 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C14141">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28102"/>
        <obo:IAO_0000115>Usually used to describe a condition that is persistent and long standing.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C14141</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P107>Chronic</obo:NCIT_P107>
        <obo:NCIT_P108>Chronic</obo:NCIT_P108>
        <obo:NCIT_P207>C0205191</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P325>A disease or condition that persists or progresses over a long period of time.</obo:NCIT_P325>
        <obo:NCIT_P325>Morphologic changes that are persistent or long standing.</obo:NCIT_P325>
        <obo:NCIT_P366>Chronic</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>CHRONIC</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Chronic</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>chronic</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C120529"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526"/>
        <rdfs:label>Chronic</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C14151 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C14151">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28103"/>
        <obo:IAO_0000115>Not capable of being removed by surgery.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C14151</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Unresectable</obo:NCIT_P108>
        <obo:NCIT_P207>C1519810</obo:NCIT_P207>
        <obo:NCIT_P322>NICHD</obo:NCIT_P322>
        <obo:NCIT_P325>Surgical removal of a lesion was not undertaken.</obo:NCIT_P325>
        <obo:NCIT_P325>Unable to be removed with surgery.</obo:NCIT_P325>
        <obo:NCIT_P366>Unresectable</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>No Resection</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Non-Resectable</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Unresectable</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>unresectable</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132009"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259"/>
        <rdfs:label>Unresectable</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C14161 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C14161">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C18000"/>
        <obo:IAO_0000115>Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28076"/>
        <obo:NCIT_NHC0>C14161</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P107>Low Grade</obo:NCIT_P107>
        <obo:NCIT_P108>Low Grade</obo:NCIT_P108>
        <obo:NCIT_P207>C1282907</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P322>ICDC</obo:NCIT_P322>
        <obo:NCIT_P325>A term used to describe cells that look nearly normal under a microscope. These cells are less likely to grow and spread more quickly than cells in high-grade cancer or in growths that may become cancer.</obo:NCIT_P325>
        <obo:NCIT_P366>Low_Grade</obo:NCIT_P366>
        <obo:NCIT_P375>Low Grade</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Low</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Low Grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>low grade</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C165451"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C175517"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Low Grade</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C14173 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C14173">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28102"/>
        <obo:IAO_0000115>Occurring again.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C14173</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P107>Recurrent</obo:NCIT_P107>
        <obo:NCIT_P108>Recurrent</obo:NCIT_P108>
        <obo:NCIT_P208>CL429630</obo:NCIT_P208>
        <obo:NCIT_P366>Recurrent</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Recurrent</oboInOwl:hasExactSynonym>
        <rdfs:label>Recurrent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C14174 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C14174">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27992"/>
        <obo:IAO_0000115>A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C14174</obo:NCIT_NHC0>
        <obo:NCIT_P106>Finding</obo:NCIT_P106>
        <obo:NCIT_P107>Metastatic</obo:NCIT_P107>
        <obo:NCIT_P108>Metastatic</obo:NCIT_P108>
        <obo:NCIT_P207>C0036525</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P325>A term referring to the pathologic observation of a tumor extension or migration from its original site of growth to another non-adjacent site.</obo:NCIT_P325>
        <obo:NCIT_P325>Having to do with metastasis, which is the spread of cancer from the primary site (place where it started) to other places in the body.</obo:NCIT_P325>
        <obo:NCIT_P366>Metastatic</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>METASTATIC</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Metastatic</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>metastatic</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90004"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90017"/>
        <rdfs:label>Metastatic</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C143099 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C143099">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C164000"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1967"/>
        <obo:IAO_0000115>Any small molecule that inhibits the enzymatic activity of the receptor tyrosine kinase c-Met (hepatocyte growth factor receptor; HGFR).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>c-Met Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C143250 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C143250">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C141144"/>
        <obo:IAO_0000115>An agent that inhibits any of the immune checkpoint inhibitory proteins.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Immune Checkpoint Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1450 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1450">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1590"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2163"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C798"/>
        <obo:IAO_0000115>A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Platinum Compound</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C146638 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C146638">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C574"/>
        <obo:IAO_0000115>Any agent that inhibits calcineurin (protein phosphatase 3; PPP3), a serine/threonine protein phosphatase dependent on calcium and calmodulin, with immunosuppressant activity. Inhibition of calcineurin prevents dephosphorylation of the transcription factor nuclear factor of activated T-cells, cytoplasmic (NFATc), which prevents its translocation to the nucleus and the subsequent induction of the expression of interleukin-2 (IL-2). This prevents IL-2-mediated proliferation and activation of T-cells, and T-lymphocyte-mediated immune responses.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Calcineurin Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1468 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1468">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2087"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C574"/>
        <obo:IAO_0000115>The morpholinoethyl ester of mycophenolic acid (MPA) with potent immunosuppressive properties.  Mycophenolate stops T-cell and B-cell proliferation through selective inhibition of the de novo pathway of purine biosynthesis.  In vivo, the active metabolite, MPA, reversibly inhibits inosine 5&apos;-monophosphate dehydrogenase, an enzyme involved in the de novo synthesis of guanine nucleotides.  MPA displays high lymphocyte specificity and cytotoxicity due to the higher dependence of activated lymphocytes on both salvage and de novo synthesis of guanine nucleotides relative to other cell types. (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Mycophenolate Mofetil</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C147908 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C147908">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:IAO_0000115>Any agent that can alter hormone levels or modulate hormone effects.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Hormone Therapy Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1490 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1490">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C860"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Taxane Compound</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1526 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1526">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1490"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C67437"/>
        <obo:IAO_0000115>A semi-synthetic, second-generation taxane derived from a compound found in the European yew tree, Taxus baccata.  Docetaxel displays potent and broad antineoplastic properties; it binds to and stabilizes tubulin, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and cell death.  This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and displays immunomodulatory and pro-inflammatory properties by inducing various mediators of the inflammatory response.  Docetaxel has been studied for use as a radiation-sensitizing agent. (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Docetaxel</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C15304 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C15304">
        <obo:IAO_0000115>A procedure that collects plasma from the peripheral blood while returning the rest to the donor.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C15304</obo:NCIT_NHC0>
        <obo:NCIT_P106>Therapeutic or Preventive Procedure</obo:NCIT_P106>
        <obo:NCIT_P107>Plasmapheresis</obo:NCIT_P107>
        <obo:NCIT_P108>Plasmapheresis</obo:NCIT_P108>
        <obo:NCIT_P207>C0032113</obo:NCIT_P207>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>NICHD</obo:NCIT_P322>
        <obo:NCIT_P325>A procedure that collects plasma from the peripheral blood while returning the rest to the donor&apos;s circulation.</obo:NCIT_P325>
        <obo:NCIT_P325>The process of separating certain cells from the plasma in the blood by a machine; only the cells are returned to the person. Plasmapheresis can be used to remove excess antibodies from the blood.</obo:NCIT_P325>
        <obo:NCIT_P366>Plasmapheresis</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Plasma Exchange</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Plasmapheresis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Therapeutic Plasma Exchange</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Therapeutic Plasmapheresis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>plasmapheresis</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118468"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259"/>
        <rdfs:label>Plasmapheresis</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C15313 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C15313">
        <obo:IAO_0000115>Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A28 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C175041"/>
        <obo:NCIT_A29 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C16035"/>
        <obo:NCIT_A29 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C16135"/>
        <obo:NCIT_A29 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C175032"/>
        <obo:NCIT_A29 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C175033"/>
        <obo:NCIT_A29 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C17649"/>
        <obo:NCIT_A29 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C66897"/>
        <obo:NCIT_A34 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C66897"/>
        <obo:NCIT_A34 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C88112"/>
        <obo:NCIT_A35 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C175041"/>
        <obo:NCIT_A38 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C16035"/>
        <obo:NCIT_A38 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C16135"/>
        <obo:NCIT_A38 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C175032"/>
        <obo:NCIT_A38 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C175033"/>
        <obo:NCIT_A38 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C17649"/>
        <obo:NCIT_A38 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C66897"/>
        <obo:NCIT_A39 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C16035"/>
        <obo:NCIT_A39 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C16135"/>
        <obo:NCIT_A39 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C66897"/>
        <obo:NCIT_NHC0>C15313</obo:NCIT_NHC0>
        <obo:NCIT_P106>Therapeutic or Preventive Procedure</obo:NCIT_P106>
        <obo:NCIT_P107>Radiation Therapy</obo:NCIT_P107>
        <obo:NCIT_P108>Radiation Therapy</obo:NCIT_P108>
        <obo:NCIT_P207>C1522449</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P322>CPTAC</obo:NCIT_P322>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>DIPG/DMG</obo:NCIT_P322>
        <obo:NCIT_P322>FDA</obo:NCIT_P322>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P322>PCDC</obo:NCIT_P322>
        <obo:NCIT_P325>Patient required additional radiation therapy.</obo:NCIT_P325>
        <obo:NCIT_P325>The use of high-energy radiation from x-rays, gamma rays, neutrons, protons, and other sources to kill cancer cells and shrink tumors. Radiation may come from a machine outside the body (external-beam radiation therapy), or it may come from radioactive material placed in the body near cancer cells (internal radiation therapy). Systemic radiation therapy uses a radioactive substance, such as a radiolabeled monoclonal antibody, that travels in the blood to tissues throughout the body.</obo:NCIT_P325>
        <obo:NCIT_P325>Use of targeted or whole body radiation to treat a disease.</obo:NCIT_P325>
        <obo:NCIT_P366>Radiation_Therapy</obo:NCIT_P366>
        <obo:NCIT_P375>Radiation Therapy, NOS</obo:NCIT_P375>
        <oboInOwl:hasDbXref>IMDRF:F2305</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>Cancer Radiotherapy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>ENERGY_TYPE</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Irradiate</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Irradiated</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Irradiation</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>RADIATION</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>RADIOTHERAPY</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>RT</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Radiation</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Radiation Therapy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Radiation Therapy, NOS</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Radiotherapeutics</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Radiotherapy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Therapy, Radiation</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>irradiated</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>irradiation</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>radiation therapy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>radiotherapy</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C101858"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132298"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156952"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156953"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156954"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156955"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C158037"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C158520"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159328"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C171094"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C174237"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C174239"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C174253"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C174255"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177384"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177403"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178113"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178115"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C179483"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C183087"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186310"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186312"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186316"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186318"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186319"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186320"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186321"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186322"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186323"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186324"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186325"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186326"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186327"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186328"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186329"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186330"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186331"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186332"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186333"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186334"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186335"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186337"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186341"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186342"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186764"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C62596"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99078"/>
        <rdfs:label>Radiation Therapy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C15383 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C15383">
        <obo:IAO_0000115>A form of therapy which includes dietary approaches and special diets that are applied as alternative therapies for risk factors or chronic disease in general.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C99532"/>
        <obo:NCIT_NHC0>C15383</obo:NCIT_NHC0>
        <obo:NCIT_P106>Therapeutic or Preventive Procedure</obo:NCIT_P106>
        <obo:NCIT_P107>Special Diet Therapy</obo:NCIT_P107>
        <obo:NCIT_P108>Special Diet Therapy</obo:NCIT_P108>
        <obo:NCIT_P207>C1519433</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P325>A form of therapy which includes dietary approaches and special diets.</obo:NCIT_P325>
        <obo:NCIT_P366>Special_Diet_Therapy</obo:NCIT_P366>
        <obo:NCIT_P375>Diet</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>DIET</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Special Diet Therapy</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C101857"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830"/>
        <rdfs:label>Special Diet Therapy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C154405 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C154405">
        <obo:IAO_0000115>Being in a state of progress or motion.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C154405</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Active State</obo:NCIT_P108>
        <obo:NCIT_P207>C0679217</obo:NCIT_P207>
        <oboInOwl:hasExactSynonym>Active</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Active State</oboInOwl:hasExactSynonym>
        <rdfs:label>Active State</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C155322 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C155322">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2336"/>
        <obo:IAO_0000115>Any agent that inhibits the serine/threonine-protein kinase BRAF(B-RAF).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>BRAF Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1556 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1556">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C272"/>
        <obo:IAO_0000115>An antimetabolite that affects the metabolism and utilization of purines.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Purine Antagonist</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1557 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1557">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C272"/>
        <obo:IAO_0000115>An antimetabolite that affects the metabolism and utilization of pyrimidines.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Pyrimidine Antagonist</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C155711 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C155711">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163760"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20401"/>
        <obo:IAO_0000115>Any monoclonal antibody that is directed against human epidermal growth factor receptor 2 (HER2; HER-2; ERBB2).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Anti-HER2 Monoclonal Antibody</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C15632 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C15632">
        <obo:IAO_0000115>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A28 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C175041"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:NCIT_A33 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177376"/>
        <obo:NCIT_A35 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C175041"/>
        <obo:NCIT_NHC0>C15632</obo:NCIT_NHC0>
        <obo:NCIT_P106>Therapeutic or Preventive Procedure</obo:NCIT_P106>
        <obo:NCIT_P107>Chemotherapy</obo:NCIT_P107>
        <obo:NCIT_P108>Chemotherapy</obo:NCIT_P108>
        <obo:NCIT_P207>C0392920</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P322>CPTAC</obo:NCIT_P322>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>DIPG/DMG</obo:NCIT_P322>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P322>PCDC</obo:NCIT_P322>
        <obo:NCIT_P325>Non-systemic chemotherapy treatment (e.g., intra-peritoneal, intra-cavitary, intra-thecal), or chemotherapy not described by Chemotherapy Single Agent Systemic or Multi-Agent Systemic.</obo:NCIT_P325>
        <obo:NCIT_P325>The use of synthetic or naturally-occurring chemicals for the treatment of diseases.</obo:NCIT_P325>
        <obo:NCIT_P325>Treatment with anticancer drugs.</obo:NCIT_P325>
        <obo:NCIT_P366>Chemotherapy</obo:NCIT_P366>
        <obo:NCIT_P375>Chemotherapy</obo:NCIT_P375>
        <obo:NCIT_P98>Although this term is used to describe any therapy involving the use of chemical-based agents, it is particularly used to refer to the use of chemical-based agents to treat cancer. Antineoplastic chemotherapy works by arresting or killing the growth and spread of cancer cells. Chemotherapy may also include agents that enhance immune function or alter hormonal activity.</obo:NCIT_P98>
        <oboInOwl:hasExactSynonym>CHEMO</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CHEMOTHERAPY</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Chemo</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Chemotherapy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Chemotherapy (NOS)</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Chemotherapy, Cancer, General</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>chemotherapy</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C101858"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156952"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156953"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156954"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156955"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C158037"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C158520"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159328"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C173231"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C174019"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C174237"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C174253"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177383"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178113"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178115"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C179478"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C179484"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C179499"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C183087"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186310"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186312"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186316"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186318"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186319"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186320"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186321"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186322"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186323"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186324"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186325"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186326"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186327"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186328"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186329"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186330"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186331"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186332"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186333"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186334"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186335"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186337"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186341"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830"/>
        <rdfs:label>Chemotherapy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C156784 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C156784">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27993"/>
        <obo:IAO_0000115>Having reached a completed state of growth and development.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C156784</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Mature</obo:NCIT_P108>
        <obo:NCIT_P207>C0205286</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P325>Having reached a completed state of development or growth; fully developed.</obo:NCIT_P325>
        <oboInOwl:hasExactSynonym>MATURE</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Mature</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Maturity</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C176226"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526"/>
        <rdfs:label>Mature</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C156893 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C156893">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C143250"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <obo:IAO_0000115>Any agent that binds to any of the ligands for the receptor programmed cell death protein 1 (PD-1; PD1); programmed death ligand 1 (PD-L1; CD274) and 2 (PD-L2; CD273).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>PD-1 Ligand Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1590 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1590">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2842"/>
        <obo:IAO_0000115>An antineoplastic agent that replaces hydrogen atom(s) in nucleophilic moieties with alky radical(s), hindering proper function. Alkylating agents exhibit cytotoxic effects through the alkylation of DNA, resulting in strand cross-linking, ultimately inhibiting DNA replication and cancer cell growth.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Antineoplastic Alkylating Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C159198 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C159198">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C129825"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163999"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1967"/>
        <obo:IAO_0000115>Any agent that inhibits the receptor tyrosine kinase mast/stem cell factor receptor c-Kit (SCFR; cKIT; CD117).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>c-KIT Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C159199 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C159199">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C164037"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1967"/>
        <obo:IAO_0000115>Any agent that inhibits the platelet-derived growth factor receptor (PDGFR).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>PDGFR Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1594 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1594">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1968"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2115"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C259"/>
        <obo:IAO_0000115>An antineoplastic antibiotic that is structurally similar to the benzoquinone ansamycin antibiotic geldanamycin. A geldanamycin analogue binds to HSP90, a chaperone protein that aids in the assembly, maturation, and folding of proteins. Subsequently, the function of HSP90 is inhibited, leading to the degradation and depletion of client proteins such as kinases and transcription factors involved with cell cycle regulation and signal transduction.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Anthracycline Antineoplastic Antibiotic</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C159438 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C159438">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C129825"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1967"/>
        <obo:IAO_0000115>Any agent that inhibits the receptor tyrosine kinase rearranged during transfection (RET).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>RET Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C16124 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C16124">
        <obo:IAO_0000115>Prior action or administration of therapeutic agents that produced an effect that is intended to alter or stop a pathologic process.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C141478"/>
        <obo:NCIT_NHC0>C16124</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Prior Therapy</obo:NCIT_P108>
        <obo:NCIT_P207>C1514463</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P322>ICDC</obo:NCIT_P322>
        <obo:NCIT_P366>Prior_Therapy</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Former Therapy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Prior Therapy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Prior Treatment</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>previously treated</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>previously_treated</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>prior therapy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>prior treatment</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>prior_therapy</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>prior_treatment</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C165451"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C166373"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C175518"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177536"/>
        <rdfs:label>Prior Therapy</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1636 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1636">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C548"/>
        <obo:IAO_0000115>Synthetically made hormones possessing the steroid ring system; e.g., androgens, estrogens, and adrenocortical hormones.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Therapeutic Steroid Hormone</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C163758 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C163758">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C274"/>
        <obo:IAO_0000115>Any agent that specifically targets or interferes with the synthesis or function of a molecule that is expressed specifically in or on cells of the tumor and/or the tumor microenvironment (TME), such as immune cells or surrounding blood vessels. The targeted molecule is usually overexpressed or mutated in tumors but minimally or not expressed by normal, healthy tissues; additionally, expression is typically associated with tumor cell proliferation, progression and/or survival. By blocking the function or expression of the tumor-associated target, the targeted therapy agent may exert potential antineoplastic and/or immunomodulatory activities.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Targeted Therapy Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C163760 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C163760">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <obo:IAO_0000115>Any agent that targets the receptor tyrosine kinase human epidermal growth factor receptor 2 (HER2/neu; HER-2; erbB-2).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>HER2-targeting Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C163952 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C163952">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <obo:IAO_0000115>Any agent that targets the human epidermal grwoth factor receptor (EGFR).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>EGFR-targeting Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C163953 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C163953">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <obo:IAO_0000115>Any agent that targets the human vascular endothelial growth factor receptor (VEGFR).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>VEGFR-targeting Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C163999 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C163999">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <obo:IAO_0000115>Any agent that targets  the receptor tyrosine kinase mast/stem cell factor receptor c-Kit (SCFR; cKIT; CD117).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>cKIT-targeting Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C164000 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C164000">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <obo:IAO_0000115>Any agent that targets the receptor tyrosine kinase c-Met (hepatocyte growth factor receptor; HGFR; cMet).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>c-Met-targeting Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C164034 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C164034">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <obo:IAO_0000115>Any agent targeting CD20.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>CD20-targeting Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C164037 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C164037">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <obo:IAO_0000115>Any agent that targets PDGFR.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>PDGFR-targeting Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1647 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1647">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C155711"/>
        <obo:IAO_0000115>A recombinant humanized monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). After binding to HER2 on the tumor cell surface, trastuzumab induces an antibody-dependent cell-mediated cytotoxicity against tumor cells that overexpress HER2. HER2 is overexpressed by many adenocarcinomas, particularly breast adenocarcinomas. (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Trastuzumab</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1702 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1702">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C141215"/>
        <obo:IAO_0000115>A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells. (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Rituximab</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1742 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1742">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C274"/>
        <obo:IAO_0000115>An agent or endogenous substance that inhibits the formation of capillaries from existing blood vessels. In cancer therapy, angiogenesis inhibitors preferentially target the new blood vessels that tumors require for oxygen and nutrition, thereby inhibiting the growth and spread of these tumors.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Angiogenesis Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1748 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1748">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C129825"/>
        <obo:IAO_0000115>Any substance that inhibits topoisomerase, an enzyme that cleaves the DNA backbone to relieve torsional stress in a DNA molecule generated during replication, transcription, and other structural transformations. Inhibition of topoisomerase causes DNA damage, inhibition of DNA replication, and apoptosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Topoisomerase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C177692 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C177692">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C35682"/>
        <obo:IAO_0000115>An indication that the expression of a gene, transcript or protein has been detected in a sample.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C177692</obo:NCIT_NHC0>
        <obo:NCIT_P106>Laboratory or Test Result</obo:NCIT_P106>
        <obo:NCIT_P108>Expression Positive</obo:NCIT_P108>
        <obo:NCIT_P208>CL1643454</obo:NCIT_P208>
        <oboInOwl:hasExactSynonym>Expressed</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Expression Detected</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Expression Positive</oboInOwl:hasExactSynonym>
        <rdfs:label>Expression Positive</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1794 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1794">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1557"/>
        <obo:IAO_0000115>A fluoropyrimidine carbamate belonging to the class of antineoplastic agents called antimetabolites.  As a prodrug, capecitabine is selectively activated by tumor cells to its cytotoxic moiety, 5-fluorouracil (5-FU); subsequently, 5-FU is metabolized to two active metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP) by both tumor cells and normal cells.  FdUMP inhibits DNA synthesis and cell division by reducing normal thymidine production, while FUTP inhibits RNA and protein synthesis by competing with uridine triphosphate for incorporation into the RNA strand. (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Capecitabine</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C18000 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C18000">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28076"/>
        <obo:IAO_0000115>The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A34 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28077"/>
        <obo:NCIT_A34 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28078"/>
        <obo:NCIT_A34 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28079"/>
        <obo:NCIT_A38 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28077"/>
        <obo:NCIT_A38 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28078"/>
        <obo:NCIT_A38 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28079"/>
        <obo:NCIT_NHC0>C18000</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Histologic Grade</obo:NCIT_P108>
        <obo:NCIT_P207>C0919553</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P322>CPTAC</obo:NCIT_P322>
        <obo:NCIT_P322>ICDC</obo:NCIT_P322>
        <obo:NCIT_P322>NAACCR</obo:NCIT_P322>
        <obo:NCIT_P322>PCDC</obo:NCIT_P322>
        <obo:NCIT_P325>A description of a tumor based on how abnormal the cancer cells look under a microscope and how quickly the tumor is likely to grow and spread. Grading systems are different for each type of cancer.</obo:NCIT_P325>
        <obo:NCIT_P325>An assigned tumor grade based on a defined scoring system.</obo:NCIT_P325>
        <obo:NCIT_P366>Histopathologic_Grade</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Grade (high/low)</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Grading</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>HISTOLOGY_GRADE</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Histologic Grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Histopathologic Grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Histopathology Grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>OVLTGRD</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Overall Tumor Grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Tumor Grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Tumor_Grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>grading</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>histological grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>histological_grade</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132262"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C132263"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156952"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C156953"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157531"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159416"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159417"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C159419"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C160911"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C165451"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C166372"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C166373"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177384"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177396"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C179490"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186764"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830"/>
        <rdfs:label>Histologic Grade</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C181581 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C181581">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C96240"/>
        <obo:IAO_0000115>A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement. It includes: T1b3, N0, M0. (partially adapted from AJCC)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C181581</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IB3</obo:NCIT_P108>
        <obo:NCIT_P208>CL1664481</obo:NCIT_P208>
        <oboInOwl:hasExactSynonym>Stage IB3</oboInOwl:hasExactSynonym>
        <rdfs:label>Stage IB3</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1851 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1851">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2160"/>
        <obo:IAO_0000115>A dipeptide boronic acid analogue with antineoplastic activity. Bortezomib reversibly inhibits the 26S proteasome, a large protease complex that degrades ubiquinated proteins. By blocking the targeted proteolysis normally performed by the proteasome, bortezomib disrupts various cell signaling pathways, leading to cell cycle arrest, apoptosis, and inhibition of angiogenesis. Specifically, the agent inhibits nuclear factor (NF)-kappaB, a protein that is constitutively activated in some cancers, thereby interfering with NF-kappaB-mediated cell survival, tumor growth, and angiogenesis. In vivo, bortezomib delays tumor growth and enhances the cytotoxic effects of radiation and chemotherapy.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Bortezomib</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C186664 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C186664">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C274"/>
        <obo:IAO_0000115>Any chemotherapeutic agent that is cytotoxic in nature and non-specifically kills rapidly proliferating cells, including tumor cells. This includes cytotoxic agents that are modified or formulated in such a way as to more specifically target tumor cells but for which the fundamental cytotoxic mechanism of action (MoA) has not changed. Targeted therapy agents that have antineoplastic MoAs are not included.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Cytotoxic Chemotherapeutic Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1904 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1904">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1748"/>
        <obo:IAO_0000115>Any substance that inhibits topoisomerase-I, a topoisomerase that relieves torsional stress in a DNA molecule by cutting only one strand of the DNA double helix. Inhibition of topoisomerase-I causes DNA damage, inhibition of DNA replication, and apoptosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Topoisomerase-I Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1907 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1907">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:IAO_0000115>Any drug derived from microorganisms, plants, or animals; also, synthesized versions of these substances or their derivatives.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Drug, Natural Product</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1908 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1908">
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Drug, Food, Chemical or Biomedical Material</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1909 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1909">
        <obo:IAO_0000115>Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Pharmacologic Substance</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1913 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1913">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1908"/>
        <obo:IAO_0000115>Substances that are grouped or classified by chemical composition.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Drug or Chemical by Structure</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1931 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1931">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1907"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C274"/>
        <obo:IAO_0000115>Plant-derived compound used to treat cancer.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Antineoplastic Plant Product</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1967 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1967">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1404"/>
        <obo:IAO_0000115>Any substance that inhibits tyrosine kinase, an enzyme involved in the transduction and processing of many extracellular and intracellular signals including cell proliferation. Inhibition of tyrosine kinase may result in inhibition of cell growth and cell proliferation.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Tyrosine Kinase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1968 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1968">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1748"/>
        <obo:IAO_0000115>Any substance that inhibits topoisomerase-II, a topoisomerase that relieves torsional stress in a DNA molecule by cutting both strands of the DNA double helix. A topoisomerase II inhibitor can either stabilize the DNA-protein complex or inhibit the catalytic activity of the enzyme. Inhibition of topoisomerase-II causes DNA damage, inhibition of DNA replication, and apoptosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Topoisomerase-II Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C1971 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C1971">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1742"/>
        <obo:IAO_0000115>An angiogenesis inhibitor that acts by blocking the action of endogenous pro-angiogenic substance(s).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Angiogenesis Activator Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2021 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2021">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C471"/>
        <obo:IAO_0000115>Any substance that inhibits thymidylate synthase, an enzyme that catalyzes the conversion of uridine monophosphate to thymidine monophosphate, the rate-limiting step in de novo production of dTMP. Inhibition of thymidylate synthase causes inhibition of DNA synthesis and cell proloferation.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Thymidylate Synthase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2039 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2039">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2496"/>
        <obo:IAO_0000115>A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine.  Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Bevacizumab</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C20401 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C20401">
        <obo:IAO_0000115>An antibody produced by a clone or genetically homogenous fast-growing cells i.e., hybridoma. Hybridoma cells are cloned to establish cell lines producing a specific antibody that is chemically and immunologically homogeneous. They are widely used in cancer detection, diagnosis, and treatment.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Monoclonal Antibody</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2078 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2078">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2140"/>
        <obo:IAO_0000115>A substance derived from folic acid that acts as a precursor or cofactor of enzymes and inhibitors involved in biosynthesis of amino acids, proteins and nucleic acid components.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Folic Acid Derivative</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2087 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2087">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C471"/>
        <obo:IAO_0000115>Any substance that inhibits inosine monophosphate dehydrogenase, an enzyme that catalyzes the conversion of inosine monophosphate to xanthosine monophosphate, the rate-limiting step in the de novo biosynthesis of guanine nucleotides. Inhibition of inosine monophosphate dehydrogenase can lead to inhibition of cell proliferation.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Inosine Monophosphate Dehydrogenase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C211 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C211">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2364"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C574"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Therapeutic Corticosteroid</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2114 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2114">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1590"/>
        <obo:IAO_0000115>A blistering agent primarily containing sulfur and chlorine groups that alkylates DNA to form DNA crosslinks, causing inhibition of DNA synthesis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Mustard Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2115 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2115">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2161"/>
        <obo:IAO_0000115>An antineoplastic agent that either covalently or noncovalently binds to the minor groove of DNA, causing inhibition of DNA synthesis. (NCI)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>DNA Minor Groove Binding Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2140 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2140">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:IAO_0000115>An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Adjuvant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2150 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2150">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C471"/>
        <obo:IAO_0000115>Any substance that inhibits ribonucleotide reductase, an enzyme that catalyzes the conversion of ribonucleoside diphosphates to deoxyribonucleotide diphosphate precursors for de novo DNA synthesis. Inhibition of ribonucleotide reductase can cause inhibition of DNA synthesis and cell growth.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Ribonucleotide Reductase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2153 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2153">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C471"/>
        <obo:IAO_0000115>Any substance that inhibits dihydrofolate reductase, an enzyme that catalyzes the conversion of dihydrofolate to tetrahydrofolate, an essential reaction for de novo glycine and purine synthesis. Inhibition of dihydrofolate reductase interferes with DNA and protein synthesis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Dihydrofolate Reductase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2160 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2160">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C471"/>
        <obo:IAO_0000115>Any substance that inhibits the proteasome complex, an enzyme complex responsible for degradation of ubiquitinated proteins. Inhibition of proteasome activity and ubiquitin-proteasome mediated proteolysis results in an accumulation of poly-ubiquitinated proteins, which may result in the disruption of cellular processes, cell cycle arrest, the induction of apoptosis, and the inhibition of tumor growth and angiogenesis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Proteasome Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2161 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2161">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2842"/>
        <obo:IAO_0000115>An agent that binds covalently or non-covalently in the major or minor groove of DNA and can disrupt DNA replication.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>DNA Groove Binding Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2163 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2163">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2842"/>
        <obo:IAO_0000115>An agent capable of attaching to DNA with a covent bond. DNA adduct forming agents cause disruption of DNA replication and mitosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>DNA Adduct Forming Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2167 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2167">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163952"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1967"/>
        <obo:IAO_0000115>Any tyrosine kinase inhibitor that targets the activity of the epidermal growth factor receptor (EGFR) tyrosine kinase. Inhibition of epidermal growth factor receptor tyrosine kinase may inhibit the growth of epidermal-lineage tumor cells, especially those that overexpress epidermal growth factor receptor.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2189 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2189">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C274"/>
        <obo:IAO_0000115>A substance that inhibits kinase enzymes and other proteins involved in signal transduction pathways to prevent tumor cell growth and induce apoptosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Signal Transduction Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2198 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2198">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C241"/>
        <obo:IAO_0000115>Nonopioid agents that produce an analgesic effect, such as NSAIDs.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Nonnarcotic Analgesic</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C221 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C221">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C718"/>
        <obo:IAO_0000115>A family or group of nitrogen-containing base compounds primarily derived from plant and animal sources.  Many alkaloids are used medicinally, including cancer therapy.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Alkaloid</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C225 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C225">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1971"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C584"/>
        <obo:IAO_0000115>A class of naturally-isolated or recombinant therapeutic peptides used as antiviral and anti-tumor agents.  Alpha interferons are cytokines produced by nucleated cells (predominantly natural killer (NK) leukocytes) upon exposure to live or inactivated virus, double-stranded RNA or bacterial products.  These agents bind to specific cell-surface receptors, resulting in the transcription and translation of genes containing an interferon-specific response element.  The proteins so produced mediate many complex effects, including antiviral effects (viral protein synthesis); antiproliferative effects (cellular growth inhibition and alteration of cellular differentiation); anticancer effects (interference with oncogene expression); and immune-modulating effects (natural killer cell activation, alteration of cell surface antigen expression, and augmentation of lymphocyte and macrophage cytotoxicity). (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Recombinant Interferon Alfa</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2336 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2336">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C61074"/>
        <obo:IAO_0000115>Any substance that inhibits Raf Kinase, an enzyme active in signal transduction in the Ras pathway. Inhibition of Raf kinase may result in reduced cell proliferation and cell death.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Raf Kinase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2356 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2356">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2198"/>
        <obo:IAO_0000115>Nonnarcotic agents that relieve pain and reduce fever.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Analgesic and Antipyretic</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2364 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2364">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1636"/>
        <obo:IAO_0000115>Pharmacological agents which affect the function of the adrenal glands.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Adrenal Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C241 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C241">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C78272"/>
        <obo:IAO_0000115>Compounds that alleviate pain without loss of consciousness.  Analgesics act by various mechanisms including binding with opioid receptors and decreasing inflammation.  Choice of analgesic may be determined by the type of pain.  These compounds include opioid, non-opioid and adjuvant analgesic agents.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Analgesic Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2496 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2496">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1742"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20401"/>
        <obo:IAO_0000115>A monoclonal antibody directed against human Vascular Endothelial Growth Factor (VEGF), a protein that stimulates angiogenesis, and prevents VEGF from binding to its receptors, causing inhibition of angiogenesis. (NCI)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Anti-VEGF Monoclonal Antibody</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C25251 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C25251">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27993"/>
        <obo:IAO_0000115>Occurring first in time or sequence; original; of greatest rank or importance or value.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C25251</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Primary</obo:NCIT_P108>
        <obo:NCIT_P208>CL448699</obo:NCIT_P208>
        <obo:NCIT_P366>Primary</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Primary</oboInOwl:hasExactSynonym>
        <rdfs:label>Primary</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C25254 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C25254">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28102"/>
        <obo:IAO_0000115>Advancing in extent or severity.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C25254</obo:NCIT_NHC0>
        <obo:NCIT_P106>Functional Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Progressive</obo:NCIT_P108>
        <obo:NCIT_P207>C0205329</obo:NCIT_P207>
        <obo:NCIT_P366>Progressive</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Progressive</oboInOwl:hasExactSynonym>
        <rdfs:label>Progressive</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C25535 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C25535">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27992"/>
        <obo:IAO_0000115>Relating to inflammation.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C25535</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Inflammatory</obo:NCIT_P108>
        <obo:NCIT_P207>C0333348</obo:NCIT_P207>
        <obo:NCIT_P366>Inflammatory</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Inflammatory</oboInOwl:hasExactSynonym>
        <rdfs:label>Inflammatory</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C25653 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C25653">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28103"/>
        <obo:IAO_0000115>Capable of being removed by surgery.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C25653</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Resectable</obo:NCIT_P108>
        <obo:NCIT_P207>C1514888</obo:NCIT_P207>
        <obo:NCIT_P325>Able to be removed by surgery.</obo:NCIT_P325>
        <obo:NCIT_P366>Resectable</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Resectable</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>resectable</oboInOwl:hasExactSynonym>
        <rdfs:label>Resectable</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C257 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C257">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2356"/>
        <obo:IAO_0000115>A pharmacological agent that is not a steroid and has potential anti-inflammatory, analgesic, antipyretic and anti-platelet activities. Most nonsteroidal anti-inflammatory drugs (NSAIDs) act by inhibiting the conversion of arachidonic acid to the precursors of prostaglandin and thromboxane by cyclooxygenase enzymes.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Nonsteroidal Antiinflammatory Drug</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C259 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C259">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186664"/>
        <obo:IAO_0000115>An antibiotic, or its derivative, that can kill or inhibit the growth of tumor cells. Antineoplastic antibiotics can interfere with the normal function of cellular nucleic acids and proteins.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Antineoplastic Antibiotic</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C25974 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C25974">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C273"/>
        <obo:IAO_0000115>Any agent that binds to tubulin molecules and interferes with the microtubule assembly and disassembly dynamic. A tubulin binding agent impedes cell division and can be used to treat a variety of cancers.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Tubulin Binding Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C263 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C263">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C78275"/>
        <obo:IAO_0000115>Any agent capable of preventing blood clot formation.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Anticoagulant Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2654 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2654">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C128036"/>
        <obo:IAO_0000115>A recombinant human immunoglobulin (Ig) G1 monoclonal antibody directed against the human T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), with immune checkpoint inhibitory and antineoplastic activities. Ipilimumab binds to CTLA4 expressed on T-cells and inhibits the CTLA4-mediated downregulation of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. CTLA4, an inhibitory receptor and member of the immunoglobulin superfamily, plays a key role in the downregulation of the immune system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Ipilimumab</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2668 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2668">
        <obo:IAO_0000115>A thalidomide analog with potential antineoplastic activity.  Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis.  This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:NCIT_A7 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20450"/>
        <obo:NCIT_A7 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20535"/>
        <obo:NCIT_A7 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20547"/>
        <obo:NCIT_NHC0>C2668</obo:NCIT_NHC0>
        <obo:NCIT_P106>Organic Chemical</obo:NCIT_P106>
        <obo:NCIT_P106>Pharmacologic Substance</obo:NCIT_P106>
        <obo:NCIT_P107>Lenalidomide</obo:NCIT_P107>
        <obo:NCIT_P108>Lenalidomide</obo:NCIT_P108>
        <obo:NCIT_P171>16085014</obo:NCIT_P171>
        <obo:NCIT_P207>C1144149</obo:NCIT_P207>
        <obo:NCIT_P210>191732-72-6</obo:NCIT_P210>
        <obo:NCIT_P319>F0P408N6V4</obo:NCIT_P319>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>FDA</obo:NCIT_P322>
        <obo:NCIT_P325>A drug that is similar to thalidomide, and is used to treat multiple myeloma and certain types of anemia. It is also being studied in the treatment of other types of cancer. Lenalidomide belongs to the family of drugs called angiogenesis inhibitors.</obo:NCIT_P325>
        <obo:NCIT_P350>C13H13N3O3</obo:NCIT_P350>
        <obo:NCIT_P366>CC-5013</obo:NCIT_P366>
        <obo:NCIT_P368>CHEBI:63791</obo:NCIT_P368>
        <obo:NCIT_P375>Lenalidomide</obo:NCIT_P375>
        <obo:NCIT_P399>38564</obo:NCIT_P399>
        <oboInOwl:hasExactSynonym>3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CC-5013</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CC5013</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CDC 501</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>LENALIDOMIDE</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Lenalidomide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Revlimid</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>lenalidomide</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C173381"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C173383"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C176424"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923"/>
        <rdfs:label>Lenalidomide</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C267 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C267">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C78272"/>
        <obo:IAO_0000115>A pharmacological agent that prevents nausea and/or vomiting.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Antiemetic Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C272 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C272">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186664"/>
        <obo:IAO_0000115>An antineoplastic agent with a structural similarity to a natural substance that can replace that substance in a normal biochemical pathway and interfere with the normal metabolic processes of cells.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Antimetabolite</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C273 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C273">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186664"/>
        <obo:IAO_0000115>An agent that inhibits tumor growth by interfering with mitotic processes or the assembly of the mitotic machinery.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Antimitotic Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C274 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C274">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:IAO_0000115>A substance that inhibits the maturation, growth or spread of tumor cells.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Antineoplastic Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27964 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27964">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28051"/>
        <obo:IAO_0000115>Cancer confined to the epithelium with formation of papillary structures without invasion of the basement membrane or noninvasive localized squamous cell carcinoma.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27964</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage 0a</obo:NCIT_P108>
        <obo:NCIT_P207>C0441764</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_0a</obo:NCIT_P366>
        <obo:NCIT_P375>Stage 0a</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage 0a</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage 0a</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27965 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27965">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28051"/>
        <obo:IAO_0000115>Cancer confined to the epithelium with formation of a flat surface without invasion of the basement membrane.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27965</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage 0is</obo:NCIT_P108>
        <obo:NCIT_P207>C0441765</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_0is</obo:NCIT_P366>
        <obo:NCIT_P375>Stage 0is</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage 0is</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage 0is</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27966 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27966">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28108"/>
        <obo:IAO_0000115>Invasive cancer confined to the original anatomic site of growth without lymph node involvement.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_A33 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C16899"/>
        <obo:NCIT_NHC0>C27966</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage I</obo:NCIT_P108>
        <obo:NCIT_P207>C0441766</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P322>PCDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_I</obo:NCIT_P366>
        <obo:NCIT_P375>Stage I</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage 1</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Stage I</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C124803"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177383"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177395"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage I</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27967 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27967">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28054"/>
        <obo:IAO_0000115>Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.  The definition of stage IIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIA is defined as follows: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIA is defined as follows: T1, N0, M0, G3, G4. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (partially adapted from AJCC 7th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27967</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIA</obo:NCIT_P108>
        <obo:NCIT_P207>C0441768</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IIA</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IIA</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIA</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIA</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27968 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27968">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28054"/>
        <obo:IAO_0000115>Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.  The definition of stage IIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIB is defined as follows: (T2, N1, MO); (T3, NO, MO). T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIB is defined as follows: T2, N0, M0, G3, G4. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (partially adapted from AJCC 7th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27968</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIB</obo:NCIT_P108>
        <obo:NCIT_P207>C0441769</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IIB</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IIB</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIB</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIB</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27969 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27969">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28054"/>
        <obo:IAO_0000115>A cancer stage generally indicating the invasion of adjacent structures by cancer without distant metastases.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27969</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIC</obo:NCIT_P108>
        <obo:NCIT_P207>C0441770</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IIC</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IIC</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIC</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIC</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27970 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27970">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28108"/>
        <obo:IAO_0000115>Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_A33 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C16899"/>
        <obo:NCIT_NHC0>C27970</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage III</obo:NCIT_P108>
        <obo:NCIT_P207>C0441771</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P322>PCDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_III</obo:NCIT_P366>
        <obo:NCIT_P375>Stage III</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage 3</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Stage III</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C124803"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177383"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177395"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage III</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27971 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27971">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28108"/>
        <obo:IAO_0000115>Cancer that has spread to distant anatomic sites beyond its original site of growth.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_A33 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C16899"/>
        <obo:NCIT_NHC0>C27971</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IV</obo:NCIT_P108>
        <obo:NCIT_P207>C0441772</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P322>PCDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IV</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IV</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage 4</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Stage IV</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C124803"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177383"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177395"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IV</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27972 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27972">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27971"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C27972</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IVS</obo:NCIT_P108>
        <obo:NCIT_P207>C0441776</obo:NCIT_P207>
        <obo:NCIT_P366>Stage_IVS</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Stage IVS</oboInOwl:hasExactSynonym>
        <rdfs:label>Stage IVS</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27975 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27975">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27966"/>
        <obo:IAO_0000115>Invasive cancer confined to the original anatomic site of growth without lymph node involvement.  The definition of stage IA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IA is defined as follows: T1, N0, M0. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IA is defined as follows: T1, N0, M0, G1, GX. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. GX: Grade cannot be assessed. (partially adapted from AJCC 8th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27975</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IA</obo:NCIT_P108>
        <obo:NCIT_P207>C0456595</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IA</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IA</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IA</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IA</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27976 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27976">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27966"/>
        <obo:IAO_0000115>Invasive cancer confined to the original anatomic site of growth without lymph node involvement.  The definition of stage IB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IB is defined as follows: (T0, N1mi, M0); (T1, N1mi, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N1mi: Nodal micrometastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IB is defined as follows: (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (partially adapted from AJCC 7th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27976</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IB</obo:NCIT_P108>
        <obo:NCIT_P207>C0456597</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IB</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IB</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IB</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IB</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27977 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27977">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27970"/>
        <obo:IAO_0000115>Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites. The definition of stage IIIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIA is defined as follows: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIA is defined as follows: T3a, N0, M0. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27977</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIIA</obo:NCIT_P108>
        <obo:NCIT_P207>C0456598</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IIIA</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IIIA</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIIA</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIIA</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27978 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27978">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27970"/>
        <obo:IAO_0000115>Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIB is defined as follows: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). N0: No regional lymph node metastasis. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIB is defined as follows: (T3b, Any N, M0); (T1-3, N1, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27978</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIIB</obo:NCIT_P108>
        <obo:NCIT_P207>C0456599</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IIIB</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IIIB</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIIB</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIIB</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27979 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27979">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27971"/>
        <obo:IAO_0000115>Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVA depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVA is defined as follows: Any T, N0, M1a, Any G. N0: No regional lymph node metastasis. M1a: Distant metastasis to lung; for vaginal cancer, stage IVA is defined as follows: T4, Any N, M0. T4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). M0: No distant metastasis. (partially adapted from AJCC 7th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27979</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IVA</obo:NCIT_P108>
        <obo:NCIT_P207>C0456600</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IVA</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IVA</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IVA</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IVA</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27980 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27980">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27971"/>
        <obo:IAO_0000115>Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVB depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVB is defined as follows: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis to other distant sites; for vaginal cancer, stage IVB is defined as follows: Any T, Any N, M1. M1: Distant metastasis. (partially adapted from AJCC 7th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27980</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IVB</obo:NCIT_P108>
        <obo:NCIT_P207>C0456601</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IVB</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IVB</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IVB</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IVB</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27981 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27981">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27966"/>
        <obo:IAO_0000115>A cancer stage generally indicating the local invasion of tissues by cancer at the primary site.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27981</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IC</obo:NCIT_P108>
        <obo:NCIT_P207>C0456607</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IC</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IC</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IC</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IC</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27982 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27982">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27970"/>
        <obo:IAO_0000115>Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIC depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIC is defined as follows: Any T, N3, M0. N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for appendix carcinoma, stage IIIC is defined as follows: Any T, N2, M0. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27982</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIIC</obo:NCIT_P108>
        <obo:NCIT_P207>C0456608</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IIIC</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IIIC</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIIC</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIIC</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27983 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27983">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27975"/>
        <obo:IAO_0000115>A stage term referring to invasive cervical and lung cancer.  For cervical cancer, it includes: T1a1, N0, M0.  T1a1: Tumor with stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread.  N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: (T1mi, N0, M0); (T1a, N0, M0). T1mi: Minimally invasive adenocarcinoma: adenocarcinoma (3 cm or less in greatest dimension) with a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27983</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IA1</obo:NCIT_P108>
        <obo:NCIT_P207>C0458828</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IA1</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IA1</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IA1</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IA1</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27984 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27984">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27975"/>
        <obo:IAO_0000115>A stage term referring to invasive cervical cancer and invasive lung cancer. For cervical cancer, it includes: T1a2, N0, M0.  T1a2: Tumor with stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: T1b, N0, M0. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C27984</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IA2</obo:NCIT_P108>
        <obo:NCIT_P207>C0458829</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IA2</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IA2</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IA2</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IA2</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27992 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27992">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C41009"/>
        <obo:IAO_0000115>An adjectival term used to specify and describe a disease appearance or processes.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C27992</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Disease Qualifier</obo:NCIT_P108>
        <obo:NCIT_P207>C1511984</obo:NCIT_P207>
        <obo:NCIT_P366>Disease_Modifier</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Disease Qualifier</oboInOwl:hasExactSynonym>
        <rdfs:label>Disease Qualifier</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C27993 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C27993">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C41009"/>
        <obo:IAO_0000115>A term that helps define and render another concept unique.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C27993</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>General Qualifier</obo:NCIT_P108>
        <obo:NCIT_P207>C1517500</obo:NCIT_P207>
        <obo:NCIT_P366>General_Modifier</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>General Modifier</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>General Qualifier</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>General Qualifiers</oboInOwl:hasExactSynonym>
        <rdfs:label>General Qualifier</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28051 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28051">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28108"/>
        <obo:IAO_0000115>Cancer confined to the epithelium without invasion of the basement membrane.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C28051</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage 0</obo:NCIT_P108>
        <obo:NCIT_P207>C0441763</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_0</obo:NCIT_P366>
        <obo:NCIT_P375>Stage 0</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage 0</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage 0</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28052 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28052">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C96240"/>
        <obo:IAO_0000115>A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: T1b1, N0, M0. (partially adapted from AJCC)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C28052</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IB1</obo:NCIT_P108>
        <obo:NCIT_P207>C1519505</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IB1</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IB1</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IB1</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IB1</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28053 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28053">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C96240"/>
        <obo:IAO_0000115>A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: T1b2, N0, M0.  (partially adapted from AJCC)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C28053</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IB2</obo:NCIT_P108>
        <obo:NCIT_P207>C1519506</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IB2</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IB2</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IB2</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IB2</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28054 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28054">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28108"/>
        <obo:IAO_0000115>Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_A33 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C16899"/>
        <obo:NCIT_NHC0>C28054</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage II</obo:NCIT_P108>
        <obo:NCIT_P207>C0441767</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P322>PCDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_II</obo:NCIT_P366>
        <obo:NCIT_P375>Stage II</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage 2</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Stage II</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C124803"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177383"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177395"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage II</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28055 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28055">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27971"/>
        <obo:IAO_0000115>Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVC depends on the particular type of cancer that it refers to; for example, for head and neck carcinomas (lip and oral cavity carcinoma, laryngeal carcinoma, nasal cavity and paranasal sinus carcinoma, pharynx carcinoma, thyroid gland carcinoma, and major salivary gland carcinoma) and head and neck mucosal melanoma, stage IVC is defined as follows: any T, any N, M1; for appendix carcinoma, stage IVC is defined as follows: any T, any N, M1b, any G. M1: Distant metastasis.  M1b: Nonperitoneal metastasis.  G: Grade (cellular differentiation).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C28055</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IVC</obo:NCIT_P108>
        <obo:NCIT_P207>C0441774</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_IVC</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IVC</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IVC</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IVC</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28064 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28064">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28108"/>
        <obo:IAO_0000115>Cancer that has spread from the original site of growth to other anatomic sites.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C28064</obo:NCIT_NHC0>
        <obo:NCIT_P106>Classification</obo:NCIT_P106>
        <obo:NCIT_P108>Extensive Stage</obo:NCIT_P108>
        <obo:NCIT_P207>C1517031</obo:NCIT_P207>
        <obo:NCIT_P366>Extensive_Stage</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Extensive Stage</oboInOwl:hasExactSynonym>
        <rdfs:label>Extensive Stage</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28065 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28065">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28108"/>
        <obo:IAO_0000115>Cancer that is localized in its original site of growth, or involves adjacent lymph nodes but has not spread to other anatomic sites.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C28065</obo:NCIT_NHC0>
        <obo:NCIT_P106>Classification</obo:NCIT_P106>
        <obo:NCIT_P108>Limited Stage</obo:NCIT_P108>
        <obo:NCIT_P207>C1517886</obo:NCIT_P207>
        <obo:NCIT_P325>A term used to describe cancer that is early in its growth, and may not have spread to other parts of the body. What is called early stage may differ between cancer types.</obo:NCIT_P325>
        <obo:NCIT_P366>Limited_Stage</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Early Stage</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Early-Stage Cancer</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Limited Metastatic Disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Limited Stage</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>early-stage cancer</oboInOwl:hasExactSynonym>
        <rdfs:label>Limited Stage</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28076 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28076">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28099"/>
        <obo:IAO_0000115>A term that refers to the cellular differentiation of a malignant cellular infiltrate. A cancer is defined through grades I-IV (or 1-4), or as well, moderately, poorly differentiated or undifferentiated.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C14158"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C14161"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28077"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28078"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28079"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28083"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C113729"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C113730"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C14158"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C14161"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28077"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28078"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28079"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28083"/>
        <obo:NCIT_NHC0>C28076</obo:NCIT_NHC0>
        <obo:NCIT_P106>Classification</obo:NCIT_P106>
        <obo:NCIT_P107>Disease Grade Qualifier</obo:NCIT_P107>
        <obo:NCIT_P108>Disease Grade Qualifier</obo:NCIT_P108>
        <obo:NCIT_P207>C1511980</obo:NCIT_P207>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P322>ICDC</obo:NCIT_P322>
        <obo:NCIT_P366>Disease_Grade_Modifier</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Disease Grade Qualifier</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>tumor grade</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>tumor_grade</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C165451"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C166373"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177536"/>
        <rdfs:label>Disease Grade Qualifier</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28099 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28099">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27992"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C28099</obo:NCIT_NHC0>
        <obo:NCIT_P106>Classification</obo:NCIT_P106>
        <obo:NCIT_P107>Disease Morphology Qualifier</obo:NCIT_P107>
        <obo:NCIT_P108>Disease Morphology Qualifier</obo:NCIT_P108>
        <obo:NCIT_P207>C1511985</obo:NCIT_P207>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P366>Disease_Morphology_Modifier</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Disease Morphology Qualifier</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <rdfs:label>Disease Morphology Qualifier</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28102 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28102">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27992"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C28102</obo:NCIT_NHC0>
        <obo:NCIT_P106>Classification</obo:NCIT_P106>
        <obo:NCIT_P108>Disease Clinical Qualifier</obo:NCIT_P108>
        <obo:NCIT_P207>C1511979</obo:NCIT_P207>
        <obo:NCIT_P366>Disease_Clinical_Modifier</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Disease Clinical Qualifier</oboInOwl:hasExactSynonym>
        <rdfs:label>Disease Clinical Qualifier</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28103 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28103">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27992"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C28103</obo:NCIT_NHC0>
        <obo:NCIT_P106>Classification</obo:NCIT_P106>
        <obo:NCIT_P108>Disease Treatment Qualifier</obo:NCIT_P108>
        <obo:NCIT_P207>C1511988</obo:NCIT_P207>
        <obo:NCIT_P366>Disease_Treatment_Modifier</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Disease Treatment Qualifier</oboInOwl:hasExactSynonym>
        <rdfs:label>Disease Treatment Qualifier</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28105 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28105">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C14174"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C28105</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Distantly Metastatic</obo:NCIT_P108>
        <obo:NCIT_P207>C1511995</obo:NCIT_P207>
        <obo:NCIT_P366>Distantly_Metastatic</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Distantly Metastatic</oboInOwl:hasExactSynonym>
        <rdfs:label>Distantly Metastatic</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28106 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28106">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C14174"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C28106</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Locally Metastatic</obo:NCIT_P108>
        <obo:NCIT_P207>C1517928</obo:NCIT_P207>
        <obo:NCIT_P366>Locally_Metastatic</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Locally Metastatic</oboInOwl:hasExactSynonym>
        <rdfs:label>Locally Metastatic</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28108 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28108">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27992"/>
        <obo:IAO_0000115>An adjectival term that can specify or describe a disease stage.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186460"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186461"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186462"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186463"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186464"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186465"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186466"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186467"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186468"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186470"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186471"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186472"/>
        <obo:NCIT_A30 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C67119"/>
        <obo:NCIT_NHC0>C28108</obo:NCIT_NHC0>
        <obo:NCIT_P106>Classification</obo:NCIT_P106>
        <obo:NCIT_P107>Disease Stage Qualifier</obo:NCIT_P107>
        <obo:NCIT_P108>Disease Stage Qualifier</obo:NCIT_P108>
        <obo:NCIT_P207>C1511987</obo:NCIT_P207>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>ICDC</obo:NCIT_P322>
        <obo:NCIT_P366>Disease_Stage_Modifier</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Disease Stage Qualifier</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>stage of disease</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>stage_of_disease</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C165451"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C166373"/>
        <rdfs:label>Disease Stage Qualifier</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C28285 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C28285">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27966"/>
        <obo:IAO_0000115>Testicular cancer found in the testicle, spermatic cord and scrotum, associated with slightly elevated levels of all tumor markers or moderately/highly elevated levels of one or more tumor markers.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C28285</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage Is</obo:NCIT_P108>
        <obo:NCIT_P207>C0730490</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P366>Stage_Is</obo:NCIT_P366>
        <obo:NCIT_P375>Stage IS</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage 1S</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Stage IS</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Stage Is</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage Is</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2842 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2842">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C186664"/>
        <obo:IAO_0000115>DNA binding molecules regulate mechanisms central to cellular function, including DNA replication and gene expression. Many small molecules that mimic or block these processes offer potential therapeutic agents. Understanding how complexation affects both the structural and mechanical properties of DNA is an important step towards understanding the functional mechanisms of binding agents, and may also provide a key to more rational drug design. There are three major classes of binding modes: intercalation, groove binding and covalent crosslinking.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>DNA Binding Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2843 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2843">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1904"/>
        <obo:IAO_0000115>Any substance based on the structure of camptothecin that stabilizes topoisomerase I-DNA covalent complexes, thereby causing DNA damage and apoptosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Camptothecin Analogue</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C287 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C287">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1323"/>
        <obo:IAO_0000115>An orally administered non-steroidal antiinflammatory agent. Acetylsalicylic acid binds to and acetylates serine residues in cyclooxygenases, resulting in decreased synthesis of prostaglandin, platelet aggregation, and inflammation. This agent exhibits analgesic, antipyretic, and anticoagulant properties.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Aspirin</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C29505 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C29505">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C29639"/>
        <obo:IAO_0000115>Any synthetic steroid derivative exhibiting the same function as the naturally occurring corticosteroid hormone, formulated for topical application. Topical corticosteroids are applied to the skin where it exerts its effect, however, corticosteroids can be absorbed systemically after being applied locally. Topical corticosteroids are mainly used for the localized treatment of inflammation of the skin and help relieve symptoms such as itching, swelling and redness.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Topical Corticosteroid</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C2959 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C2959">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C36291"/>
        <obo:IAO_0000115>Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C2959</obo:NCIT_NHC0>
        <obo:NCIT_P106>Finding</obo:NCIT_P106>
        <obo:NCIT_P108>Complication</obo:NCIT_P108>
        <obo:NCIT_P207>C0009566</obo:NCIT_P207>
        <obo:NCIT_P322>NICHD</obo:NCIT_P322>
        <obo:NCIT_P325>In medicine, a medical problem that occurs during a disease, or after a procedure or treatment. The complication may be caused by the disease, procedure, or treatment or may be unrelated to them.</obo:NCIT_P325>
        <obo:NCIT_P366>Complication</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Complication</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Complications</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Medical Complication</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>complication</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99147"/>
        <rdfs:label>Complication</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C29629 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C29629">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:IAO_0000115>A medication containing two or more active ingredients acting in a synergistic or potentiating manner to treat a disease state.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Combination Medication</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C29639 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C29639">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C29629"/>
        <obo:IAO_0000115>Natural or synthetic compounds or mixtures that are applied to body surfaces such as the skin, mouth, vagina, lips, nose, ears or the eyes. A topical preparation can act only on the specific area to which it is applied or it can be applied locally to be absorbed into the blood stream and act systemically.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Topical Preparation</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C30103 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C30103">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28102"/>
        <obo:IAO_0000115>Subject to little fluctuation; showing little if any change.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C30103</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Stable</obo:NCIT_P108>
        <obo:NCIT_P207>C0205360</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P322>DIPG/DMG</obo:NCIT_P322>
        <obo:NCIT_P322>FDA</obo:NCIT_P322>
        <obo:NCIT_P325>Subject to little fluctuation; showing little if any change. (NCI)</obo:NCIT_P325>
        <obo:NCIT_P366>Stable</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>STABLE</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Stable</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C183087"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C96785"/>
        <rdfs:label>Stable</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C307 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C307">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:IAO_0000115>Biotechnology-derived pharmaceutical agents made from living organisms or their products. Includes recombinant proteins, monoclonal antibodies, and nucleic acids.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Biological Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C308 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C308">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:IAO_0000115>Any substance that induces, enhances, restores or suppresses the host&apos;s immune system, or an agent that utilizes or is derived from a component of the immune system.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Immunotherapeutic Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C3367 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C3367">
        <obo:IAO_0000115>Clinical, laboratory or molecular evidence, or absence of evidence of disease.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C3367</obo:NCIT_NHC0>
        <obo:NCIT_P106>Finding</obo:NCIT_P106>
        <obo:NCIT_P107>Finding</obo:NCIT_P107>
        <obo:NCIT_P108>Finding</obo:NCIT_P108>
        <obo:NCIT_P207>C1285578</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC-GLOSS</obo:NCIT_P322>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>NICHD</obo:NCIT_P322>
        <obo:NCIT_P325>A meaningful interpretation of data or observations resulting from planned evaluations. Compare to conclusion, hypothesis. See also general observation class, intervention, event.</obo:NCIT_P325>
        <obo:NCIT_P366>Finding</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Finding</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Observable Entity</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>finding</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C89506"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259"/>
        <rdfs:label>Finding</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C35681 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C35681">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C77140"/>
        <obo:IAO_0000115>A test result that indicates that a specific disease, condition, or attribute being assessed is not present.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C35681</obo:NCIT_NHC0>
        <obo:NCIT_P106>Finding</obo:NCIT_P106>
        <obo:NCIT_P108>Negative Test Result</obo:NCIT_P108>
        <obo:NCIT_P207>C1334932</obo:NCIT_P207>
        <obo:NCIT_P322>SeroNet</obo:NCIT_P322>
        <obo:NCIT_P325>A test result that does not show the specific disease, condition, or biomarker for which the test is being done.</obo:NCIT_P325>
        <obo:NCIT_P366>Negative_Test_Result</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Negative</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Negative Test Result</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>negative test result</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178719"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C179027"/>
        <rdfs:label>Negative Test Result</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C35682 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C35682">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C36292"/>
        <obo:IAO_0000115>A laboratory test result that indicates that a specific disease, condition, or attribute being assessed is present.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C35682</obo:NCIT_NHC0>
        <obo:NCIT_P106>Laboratory or Test Result</obo:NCIT_P106>
        <obo:NCIT_P108>Positive Laboratory Test Result</obo:NCIT_P108>
        <obo:NCIT_P207>C1335447</obo:NCIT_P207>
        <obo:NCIT_P322>SeroNet</obo:NCIT_P322>
        <obo:NCIT_P325>A test result that reveals the presence of a specific disease or condition for which the test is being done.</obo:NCIT_P325>
        <obo:NCIT_P366>Positive_Test_Result</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Positive</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Positive Laboratory Test Result</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>positive test result</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178719"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C179027"/>
        <rdfs:label>Positive Laboratory Test Result</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C362 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C362">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C697"/>
        <obo:IAO_0000115>An orally-active antineoplastic aromatic nitrogen mustard. Chlorambucil alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Chlorambucil</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C36291 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C36291">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C3367"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C36291</obo:NCIT_NHC0>
        <obo:NCIT_P106>Finding</obo:NCIT_P106>
        <obo:NCIT_P108>Finding by Cause</obo:NCIT_P108>
        <obo:NCIT_P207>C1333617</obo:NCIT_P207>
        <obo:NCIT_P366>Finding_by_Cause</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Finding by Cause</oboInOwl:hasExactSynonym>
        <rdfs:label>Finding by Cause</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C36292 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C36292">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C77140"/>
        <obo:IAO_0000115>The outcome of a laboratory test.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C26683"/>
        <obo:NCIT_A31 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C73705"/>
        <obo:NCIT_NHC0>C36292</obo:NCIT_NHC0>
        <obo:NCIT_P106>Laboratory or Test Result</obo:NCIT_P106>
        <obo:NCIT_P107>Laboratory Test Result</obo:NCIT_P107>
        <obo:NCIT_P108>Laboratory Test Result</obo:NCIT_P108>
        <obo:NCIT_P207>C0587081</obo:NCIT_P207>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>FDA</obo:NCIT_P322>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P322>NICHD</obo:NCIT_P322>
        <obo:NCIT_P322>PCDC</obo:NCIT_P322>
        <obo:NCIT_P366>Test_Result</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>LAB_RESULT</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Lab Findings</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Laboratory Finding</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Laboratory Report</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Laboratory Test Result</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Labs</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>TEST RESULT</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Test Result</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>test result</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>test_result</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C118169"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C173206"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C174018"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C174239"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C174250"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177384"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177398"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177536"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178106"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178117"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C179492"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186323"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186342"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186764"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C54447"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C89506"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C90259"/>
        <rdfs:label>Laboratory Test Result</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C376 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C376">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1450"/>
        <obo:IAO_0000115>An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Cisplatin</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C38014 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C38014">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28103"/>
        <obo:IAO_0000115>Not responding to treatment.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A35 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C168878"/>
        <obo:NCIT_NHC0>C38014</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Refractory</obo:NCIT_P108>
        <obo:NCIT_P207>C0205269</obo:NCIT_P207>
        <obo:NCIT_P322>DIPG/DMG</obo:NCIT_P322>
        <obo:NCIT_P322>PCDC</obo:NCIT_P322>
        <obo:NCIT_P325>In medicine, describes a disease or condition that does not respond to treatment.</obo:NCIT_P325>
        <obo:NCIT_P366>Refractory</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Refractory</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Unresponsive</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Unresponsive to Treatment</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>refractory</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178098"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178100"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178115"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178123"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C178124"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C183078"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C183079"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186282"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186310"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186311"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186316"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186317"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186318"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186319"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186320"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186321"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186322"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186323"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186324"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186325"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186326"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186327"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186328"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186329"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186330"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186331"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186332"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186333"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186334"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186335"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C186341"/>
        <rdfs:label>Refractory</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C38718 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C38718">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C159198"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C159199"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C93259"/>
        <obo:IAO_0000115>An orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Axitinib</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C405 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C405">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C574"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C697"/>
        <obo:IAO_0000115>A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Cyclophosphamide</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C41009 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C41009">
        <obo:IAO_0000115>A term that helps define and render a concept unique.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C41009</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Qualifier</obo:NCIT_P108>
        <obo:NCIT_P207>C1514623</obo:NCIT_P207>
        <obo:NCIT_P366>Qualifier</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Modifier</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Qualifier</oboInOwl:hasExactSynonym>
        <rdfs:label>Qualifier</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C422 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C422">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C267"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C521"/>
        <obo:IAO_0000115>A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Dexamethasone</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C43623 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C43623">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27993"/>
        <obo:IAO_0000115>Retained; never-ceasing.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C43623</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P107>Persistent</obo:NCIT_P107>
        <obo:NCIT_P108>Persistent</obo:NCIT_P108>
        <obo:NCIT_P207>C0205322</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P325>Retained; never-ceasing.</obo:NCIT_P325>
        <obo:NCIT_P366>Persistent</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>PERSISTENT</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Persistent</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C124310"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C142799"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526"/>
        <rdfs:label>Persistent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C456 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C456">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C67502"/>
        <obo:IAO_0000115>An anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids; the formation of oxygen free radicals also contributes to the toxicity of the anthracycline antibiotics, namely the cardiac and cutaneous vascular effects.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Doxorubicin</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C471 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C471">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:IAO_0000115>A pharmacological agent that inhibits the catalytic activity of an enzyme.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Enzyme Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C48044 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C48044">
        <obo:IAO_0000115>A substance from which another substance is formed.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C48044</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Precursor</obo:NCIT_P108>
        <obo:NCIT_P207>C1709634</obo:NCIT_P207>
        <obo:NCIT_P366>Precursor</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Precursor</oboInOwl:hasExactSynonym>
        <rdfs:label>Precursor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C491 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C491">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1331"/>
        <obo:IAO_0000115>A semisynthetic derivative of podophyllotoxin, a substance extracted from the mandrake root Podophyllum peltatum.  Possessing potent antineoplastic properties, etoposide binds to and inhibits topoisomerase II and its function in ligating cleaved DNA molecules, resulting in the accumulation of single- or double-strand DNA breaks, the inhibition of DNA replication and transcription, and apoptotic cell death.  Etoposide acts primarily in the G2 and S phases of the cell cycle. (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Etoposide</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C505 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C505">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2021"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C94728"/>
        <obo:IAO_0000115>An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. Fluorouracil and its metabolites possess a number of different mechanisms of action. In vivo, fluoruracil is converted to the active metabolite 5-fluoroxyuridine monophosphate (F-UMP); replacing uracil, F-UMP incorporates into RNA and inhibits RNA processing, thereby inhibiting cell growth. Another active metabolite, 5-5-fluoro-2&apos;-deoxyuridine-5&apos;-O-monophosphate (F-dUMP), inhibits thymidylate synthase, resulting in the depletion of thymidine triphosphate (TTP), one of the four nucleotide triphosphates used in the in vivo synthesis of DNA. Other fluorouracil metabolites incorporate into both RNA and DNA; incorporation into RNA results in major effects on both RNA processing and functions.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Fluorouracil</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C511 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C511">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C272"/>
        <obo:IAO_0000115>A compound with a chemical structure similar to folic acid. Folate antagonists inhibit one or more folate-dependent enzymes, resulting in decreased DNA, RNA and protein synthesis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Folate Antagonist</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C521 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C521">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C211"/>
        <obo:IAO_0000115>Synthetically derived forms of the naturally occurring Glucocorticoids.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Therapeutic Glucocorticoid</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C52186 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C52186">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20401"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C574"/>
        <obo:IAO_0000115>A recombinant, chimeric, human-murine monoclonal antibody directed against the alpha subunit of the interleukin-2 receptor (IL-2R alpha) with immunosuppressant activity. Basiliximab selectively binds to and blocks IL-2R alpha, expressed on the surface of activated T-lymphocytes, thereby preventing interleukin-2 binding and inhibiting the interleukin-2-mediated activation of lymphocytes.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Basiliximab</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C52196 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C52196">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2160"/>
        <obo:IAO_0000115>An epoxomicin derivate with potential antineoplastic activity. Carfilzomib irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S catalytic core subunit of the proteasome, a protease complex responsible for degrading a large variety of cellular proteins. Inhibition of proteasome-mediated proteolysis results in an accumulation of polyubiquinated proteins, which may lead to cell cycle arrest, induction of apoptosis, and inhibition of tumor growth.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Carfilzomib</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C52200 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C52200">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C143099"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C159438"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C93259"/>
        <obo:IAO_0000115>An orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several RTKs, which are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (MET), RET (rearranged during transfection), vascular endothelial growth factor receptor types 1 (VEGFR-1), 2 (VEGFR-2), and 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS-like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin-related kinase B (TRKB) and AXL. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Cabozantinib</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C539 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C539">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C263"/>
        <obo:IAO_0000115>A sulfur-rich glycosaminoglycan with anticoagulant property. Heparin binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors, such as factors IX, X, XI, and XII, thereby preventing the polymerization of fibrinogen to fibrin and the subsequent formation of clots.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Heparin</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C54035 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C54035">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27993"/>
        <obo:IAO_0000115>Causing fear or anxiety by threatening great harm; of great consequence.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C54035</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Serious</obo:NCIT_P108>
        <obo:NCIT_P207>C0205404</obo:NCIT_P207>
        <obo:NCIT_P366>Serious</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Serious</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Seriousness</oboInOwl:hasExactSynonym>
        <rdfs:label>Serious</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C548 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C548">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C147908"/>
        <obo:IAO_0000115>Any synthetic or animal-derived agent that is chemically identical or similar to an endogenous hormone with therapeutic application.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Therapeutic Hormone</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C552 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C552">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C718"/>
        <obo:IAO_0000115>A group of organic compounds that consist of only hydrogen (H) and carbon (C) atoms and are involved in energy production. They may be cyclic or non-cyclic compounds. They may have double bonds, single bonds or both with carbon forming the backbone.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Hydrocarbon</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C574 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C574">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C308"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Immunosuppressant</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C584 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C584">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1283"/>
        <obo:IAO_0000115>One of a group of recombinant therapeutic glycoprotein cytokines with antiviral, anti-proliferative, and immunomodulating activities. Interferons bind to specific cell-surface receptors, leading to the transcription and translation of genes with interferon-specific response elements (ISREs). The resultant proteins mediate many complex effects, ultimately leading to inhibition of viral protein synthesis and cellular growth, alteration of cellular differentiation, interference with oncogene expression, activation of natural killer cells, alteration of cell surface antigen expression, and augmentation of lymphocyte and macrophage cytotoxicity. The production of endogenous interferons is induced in response to foreign agents such as bacteria, viruses and parasites and to tumor cells.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Recombinant Interferon</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C587 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C587">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C593"/>
        <obo:IAO_0000115>Any recombinant analog of endogenous interleukin-2 (IL-2), a cytokine involved in intercellular communication related to cell differentiation, proliferation, inflammation, hematopoiesis, neuronal functions, and release of hormones. IL-2 binds to and activates specific receptors, triggering expression of specific genes, and may induce T cell-mediated tumor regression in some tumor types.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Recombinant Interleukin-2</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C593 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C593">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1283"/>
        <obo:IAO_0000115>Formulated therapeutic analogs of one of a number of endogenous cytokine interleukins.  Produced by T cells, macrophages, and other cells, interleukins bind to a specific surface receptor on immunohematopoietic cells, thereby inducing a multitude of biologic effects including stimulation of growth, differentiation, and proliferation of lymphocytes and eosinophils; activation of lymphocytes and macrophages; enhancement of mast cell activity; activation of the acute phase response; and stimulation of hematopoiesis.  Some interleukins may enhance the host&apos;s immune response to malignant cells by stimulating lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL), which are capable of lysing some tumor cells. (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Recombinant Interleukin</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C61074 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C61074">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1404"/>
        <obo:IAO_0000115>Any substance that inhibits serine/threonine protein kinase, an enzyme that phosphorylates the hydroxyl group of serine or threonine on various proteins in various signaling cascades. Inhibition of serine/threonine protein kinase can inhibit cell proliferation and induce apoptosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Serine/Threonine Kinase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C61362 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C61362">
        <obo:IAO_0000115>Any small spherical group of cells containing a cavity.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C61362</obo:NCIT_NHC0>
        <obo:NCIT_P106>Body Part, Organ, or Organ Component</obo:NCIT_P106>
        <obo:NCIT_P108>Follicle</obo:NCIT_P108>
        <obo:NCIT_P207>C1571705</obo:NCIT_P207>
        <obo:NCIT_P325>A sac or pouch-like cavity formed by a group of cells. In the ovaries, one follicle contains one egg. In the skin, one follicle contains one hair.</obo:NCIT_P325>
        <obo:NCIT_P366>Follicle</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Follicle</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Follicular</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>follicle</oboInOwl:hasExactSynonym>
        <rdfs:label>Follicle</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C616 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C616">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C718"/>
        <obo:IAO_0000115>A class of hydrocarbon-containing organic compounds. Lipids are insoluble in water but soluble in nonpolar solvents and play important roles in living organisms: these roles include functioning as energy storage molecules, serving as structural components of cell membranes, and constituting important signaling molecules. Lipids can be subdivided into 2 groups: fatty acids and glycerides.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Lipid</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C61614 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C61614">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2021"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C511"/>
        <obo:IAO_0000115>A synthetic pyrimidine-based antifolate. Pemetrexed binds to and inhibits the enzyme thymidylate synthase (TS), which catalyses the methylation of 2&apos;-deoxyuridine-5&apos;-monophosphate (dUMP) to 2&apos;-deoxythymidine-5&apos;-monophosphate (dTMP), an essential precursor in DNA synthesis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Pemetrexed</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C62040 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C62040">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2843"/>
        <obo:IAO_0000115>A semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata.  Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme.  One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death.  Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Irinotecan</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C633 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C633">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C697"/>
        <obo:IAO_0000115>A phenylalanine derivative of nitrogen mustard with antineoplastic activity. Melphalan alkylates DNA at the N7 position of guanine and induces DNA inter-strand cross-linkages, resulting in the inhibition of DNA and RNA synthesis and cytotoxicity against both dividing and non-dividing tumor cells.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Melphalan</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C63593 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C63593">
        <obo:IAO_0000115>A chemotherapy regimen consisting of leucovorin calcium (calcium folinate), 5-fluorouracil, and irinotecan used in the treatment of advanced-stage and metastatic colorectal cancer.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C63593</obo:NCIT_NHC0>
        <obo:NCIT_P106>Therapeutic or Preventive Procedure</obo:NCIT_P106>
        <obo:NCIT_P107>FOLFIRI Regimen</obo:NCIT_P107>
        <obo:NCIT_P108>FOLFIRI Regimen</obo:NCIT_P108>
        <obo:NCIT_P207>C1880658</obo:NCIT_P207>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P325>An abbreviation for a chemotherapy combination used to treat advanced colorectal cancer that has spread. It is also being studied in the treatment of other types of cancer. It includes the drugs leucovorin calcium (folinic acid), fluorouracil, and irinotecan hydrochloride.</obo:NCIT_P325>
        <obo:NCIT_P366>FOLFIRI_Regimen</obo:NCIT_P366>
        <obo:NCIT_P399>41990</obo:NCIT_P399>
        <obo:NCIT_P98>Source: NCCN Guidelines 2007</obo:NCIT_P98>
        <oboInOwl:hasExactSynonym>FOLFIRI</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>FOLFIRI Regimen</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>FOLFIRI regimen</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Fluorouracil-Folinic Acid-Irinotecan</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Fluorouracil/Folinic Acid/Irinotecan</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Folinic Acid-Fluorouracil-Irinotecan Regimen</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Folinic Acid/Fluorouracil/Irinotecan Regimen</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C160950"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C160952"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C176424"/>
        <rdfs:label>FOLFIRI Regimen</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C63764 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C63764">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27993"/>
        <obo:IAO_0000115>Widespread, broadly dispersed, common.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C63764</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Generalized</obo:NCIT_P108>
        <obo:NCIT_P207>C0205246</obo:NCIT_P207>
        <obo:NCIT_P366>Generalized</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>General</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Generalized</oboInOwl:hasExactSynonym>
        <rdfs:label>Generalized</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C642 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C642">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2153"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C511"/>
        <obo:IAO_0000115>An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Methotrexate</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C64768 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C64768">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C129825"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C155322"/>
        <obo:IAO_0000115>An orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity. Vemurafenib selectively binds to the ATP-binding site of BRAF(V600E) kinase and inhibits its activity, which may result in an inhibition of an over-activated MAPK signaling pathway downstream in BRAF(V600E) kinase-expressing tumor cells and a reduction in tumor cell proliferation. Approximately 90% of BRAF gene mutations involve a valine-to-glutamic acid mutation at residue 600 (V600E); the oncogene protein product, BRAF(V600E) kinase, exhibits a markedly elevated activity that over-activates the MAPK signaling pathway. The BRAF(V600E) gene mutation has been found to occur in approximately 60% of melanomas, and in about 8% of all solid tumors, including melanoma, colorectal, thyroid and other cancers.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Vemurafenib</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C65530 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C65530">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C129825"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2167"/>
        <obo:IAO_0000115>A quinazoline derivative with antineoplastic properties.  Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Erlotinib</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C66876 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C66876">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1557"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2150"/>
        <obo:IAO_0000115>A broad-spectrum antimetabolite and deoxycytidine analogue with antineoplastic activity. Upon administration, gemcitabine is converted into the active metabolites difluorodeoxycytidine diphosphate (dFdCDP) and difluorodeoxycytidine triphosphate (dFdCTP) by deoxycytidine kinase. dFdCTP competes with deoxycytidine triphosphate (dCTP) and is incorporated into DNA.  This locks DNA polymerase thereby resulting in &quot;masked termination&quot; during DNA replication. On the other hand, dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis. The reduction in the intracellular concentration of dCTP potentiates the incorporation of dFdCTP into DNA.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Gemcitabine</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C67422 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C67422">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C25974"/>
        <obo:IAO_0000115>Any of a class of anti-mitotic compounds that bind to the vinca site of the beta tubulin subunit, a region located within the middle domain of the tubulin structure and corresponding with a residue sequence approximating 177-215. The agent binds to the vinca site to produce a conformational change in the protofilament structure and at high concentrations, to induce the formation of spirals and crystal aggregates; these changes impair the polymerization of tubulin dimers and thereby, prevent the assembly of microtubules. The subsequent decrease in the amount of formed microtubules causes disassembly of the mitotic spindle resulting from instability of the structure during the mitotic interphase, eventually leading to cell cycle arrest and/or apoptosis. Vinca-site binding agents include natural compounds isolated from the periwinkle (Catharanthus roseus, formally, Vinca roseus) plant and synthetic compounds.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Vinca-Domain Binding Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C67437 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C67437">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C25974"/>
        <obo:IAO_0000115>Any of a class of anti-mitotic compounds that bind to the taxane site of the beta-tubulin subunit, a region described as a binding pocket located within the middle domain and corresponding to an approximate residue sequence of 217-231. Specifically, these agents bind to a cysteine residue within the pocket, which is also the binding site for GTP. Agents binding at the taxane site promote the polymerization of dimers to form a very rigid and stable microtubule structure which is not readily disassembled. By interfering with microtubule dynamics these agents inhibit the normal turnover process essential during mitosis, thereby causing cell-cycle arrest and/or apoptosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Taxane-Pocket Binding Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C67502 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C67502">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1594"/>
        <obo:IAO_0000115>A compound drug containing doxorubicin as an active ingredient.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Doxorubicin Preparation</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C68814 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C68814">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C128037"/>
        <obo:IAO_0000115>A fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. Upon administration, nivolumab binds to and blocks the activation of PD-1, an immunoglobulin superfamily (IgSF) transmembrane protein, by its ligands programmed cell death ligand 1 (PD-L1), which is overexpressed on certain cancer cells, and programmed cell death ligand 2 (PD-L2), which is primarily expressed on antigen-presenting cells (APCs). This results in the activation of T-cells and cell-mediated immune responses against tumor cells. Activated PD-1 negatively regulates T-cell activation and plays a key role in tumor evasion from host immunity.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Nivolumab</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C68923 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C68923">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C129825"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C69145"/>
        <obo:IAO_0000115>An orally bioavailable small-molecule inhibitor of mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), with potential antineoplastic activity. Cobimetinib specifically binds to and inhibits the catalytic activity of MEK1, resulting in inhibition of extracellular signal-related kinase 2 (ERK2) phosphorylation and activation and decreased tumor cell proliferation. Preclinical studies have demonstrated that this agent is effective in inhibiting the growth of tumor cells bearing a B-RAF mutation, which has been found to be associated with many tumor types. A threonine-tyrosine kinase and a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors, MEK1 is required for the transmission of growth-promoting signals from numerous receptor tyrosine kinases.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Cobimetinib</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C69145 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C69145">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1404"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163758"/>
        <obo:IAO_0000115>Any substance that inhibits mitogen-activated protein kinase kinase (MEK), an enzyme that catalyzes the addition of a phosphate group to a mitogen-activated protein kinase. Inhibition of mitogen-activated protein kinase kinase results in the inhibition of cell proliferation.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Mitogen-Activated Protein Kinase Kinase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C697 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C697">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2114"/>
        <obo:IAO_0000115>A mustard agent containing nitrogen and chlorine atoms.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Nitrogen Mustard Compound</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C7057 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C7057">
        <obo:IAO_0000115>A condition that is relevant to human neoplasms and non-neoplastic disorders.  This includes observations, test results, history and other concepts relevant to the characterization of human pathologic conditions.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C7057</obo:NCIT_NHC0>
        <obo:NCIT_P106>Conceptual Entity</obo:NCIT_P106>
        <obo:NCIT_P108>Disease, Disorder or Finding</obo:NCIT_P108>
        <obo:NCIT_P207>C1511989</obo:NCIT_P207>
        <obo:NCIT_P366>Diseases_Disorders_and_Findings</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Disease, Disorder or Finding</oboInOwl:hasExactSynonym>
        <rdfs:label>Disease, Disorder or Finding</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C70667 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C70667">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27993"/>
        <obo:IAO_0000115>Intensely bad or unpleasant in degree, quality or extent.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C70667</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Severe</obo:NCIT_P108>
        <obo:NCIT_P207>C0205082</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P322>CDISC-GLOSS</obo:NCIT_P322>
        <obo:NCIT_P322>DIPG/DMG</obo:NCIT_P322>
        <obo:NCIT_P325>An adjective for grading intensity on a relative scale describing a symptom, outcome or event. Note: The term &apos;severe&apos; is often used to describe the intensity (severity) of a specific event (as in mild, moderate, or severe myocardial infarction); the event itself, however, may be of relatively minor medical significance (such as severe headache). This is not the same as &apos;serious,&apos; which is based on patient/event outcome or action criteria usually associated with events that pose a threat to a patient&apos;s life or functioning. Seriousness (not severity) serves as a guide for defining regulatory reporting obligations. [After ICH E2A, B] See also serious adverse event and serious adverse drug reaction.</obo:NCIT_P325>
        <obo:NCIT_P325>Intensely bad or major in degree, quality or extent.</obo:NCIT_P325>
        <obo:NCIT_P366>Severe</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>SEVERE</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Severe</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Severely</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>severe</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C103843"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C165643"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C183105"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C67497"/>
        <rdfs:label>Severely</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C71631 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C71631">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C2078"/>
        <obo:IAO_0000115>A derivative of folic acid with chemoprotectant, antidote and synergistic activity. Leucovorin does not require metabolism by dihydrofolate reductase, the molecular target of folate antagonist-type chemotherapeutic drugs, and is converted to a tetrahydrofolate, which is the necessary folate for purine and pyrimidine synthesis. As this agent allows for some purine/pyrimidine synthesis to occur, the toxic effects of folic acid antagonist-type chemotherapeutic drugs are counteracted while still permitting the antitumor activity of the folic acid antagonist through dihydrofolate reductase inhibition. This agent also potentiates the effects of 5-fluorouracil and its derivatives by stabilizing the binding of 5-fluorouracil&apos;s converted form fluorodeoxyuridylic acid to its target enzyme thymidylate synthase, thus prolonging drug activity.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Leucovorin</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C718 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C718">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1913"/>
        <obo:IAO_0000115>Molecule that contains atoms of the element carbon, usually combined with itself and with atoms of one or more other element such as hydrogen, oxygen, nitrogen, sulfur, phosphorus, chlorine, or fluorine. Excludes carbides, carbonates and carbon oxides.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Organic Chemical</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C72560 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C72560">
        <obo:IAO_0000115>An orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF-alpha production, enhance the activity of T cells and natural killer (NK) cells and enhance antibody-dependent cellular cytotoxicity (ADCC). In addition, pomalidomide may inhibit tumor angiogenesis, promote cell cycle arrest in susceptible tumor cell populations, and stimulate erythropoeisis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:NCIT_NHC0>C72560</obo:NCIT_NHC0>
        <obo:NCIT_P106>Organic Chemical</obo:NCIT_P106>
        <obo:NCIT_P106>Pharmacologic Substance</obo:NCIT_P106>
        <obo:NCIT_P107>Pomalidomide</obo:NCIT_P107>
        <obo:NCIT_P108>Pomalidomide</obo:NCIT_P108>
        <obo:NCIT_P171>16085014</obo:NCIT_P171>
        <obo:NCIT_P207>C2347624</obo:NCIT_P207>
        <obo:NCIT_P210>19171-19-8</obo:NCIT_P210>
        <obo:NCIT_P319>D2UX06XLB5</obo:NCIT_P319>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>FDA</obo:NCIT_P322>
        <obo:NCIT_P325>A substance being studied in the treatment of prostate cancer, multiple myeloma, and other types of cancer. Pomalidomide is a form of the drug thalidomide. It stops the growth of blood vessels, stimulates the immune system, and may kill cancer cells. Pomalidomide is a type of angiogenesis inhibitor and a type of immunomodulatory agent.</obo:NCIT_P325>
        <obo:NCIT_P350>C13H11N3O4</obo:NCIT_P350>
        <obo:NCIT_P366>Pomalidomide</obo:NCIT_P366>
        <obo:NCIT_P375>Pomalidomide</obo:NCIT_P375>
        <obo:NCIT_P399>653314</obo:NCIT_P399>
        <oboInOwl:hasExactSynonym>3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>4-Aminothalidomide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Actimid</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CC-4047</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Imnovid</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>POMALIDOMIDE</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Pomalidomide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Pomalyst</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>pomalidomide</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C176424"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923"/>
        <rdfs:label>Pomalidomide</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C73261 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C73261">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C697"/>
        <obo:IAO_0000115>A bifunctional mechlorethamine derivative with alkylating and antimetabolite activities. Although the exact mechanism of action of bendamustine is unknown, this agent appears to alkylate and crosslink macromolecules, resulting in DNA, RNA and protein synthesis inhibition, and eventually the induction of apoptosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Bendamustine</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C73705 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C73705">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27993"/>
        <obo:IAO_0000115>Lying between two extremes in time or space or degree.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C106317"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C36292"/>
        <obo:NCIT_NHC0>C73705</obo:NCIT_NHC0>
        <obo:NCIT_P106>Qualitative Concept</obo:NCIT_P106>
        <obo:NCIT_P108>Intermediate</obo:NCIT_P108>
        <obo:NCIT_P207>C0205103</obo:NCIT_P207>
        <obo:NCIT_P322>CDISC</obo:NCIT_P322>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P325>Located between two points or extremes.</obo:NCIT_P325>
        <obo:NCIT_P366>Intermediate</obo:NCIT_P366>
        <obo:NCIT_P375>Intermediate</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>INTERMEDIATE</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Intermediate</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Intermediate/Normal</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C61410"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C66830"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C77526"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C99074"/>
        <rdfs:label>Intermediate</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C74095 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C74095">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C36292"/>
        <obo:IAO_0000115>Determination of presence or absence of CD20 antigen.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C74095</obo:NCIT_NHC0>
        <obo:NCIT_P106>Laboratory or Test Result</obo:NCIT_P106>
        <obo:NCIT_P108>CD20 Antigen Status</obo:NCIT_P108>
        <obo:NCIT_P207>C2347250</obo:NCIT_P207>
        <obo:NCIT_P366>CD20_Antigen_Status</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>CD20 Antigen Status</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CD20 Status</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Leu-16 Status</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>MS4A1 Status</oboInOwl:hasExactSynonym>
        <rdfs:label>CD20 Antigen Status</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C770 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C770">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C521"/>
        <obo:IAO_0000115>A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Prednisone</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C77140 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C77140">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C3367"/>
        <obo:IAO_0000115>The result of a laboratory, radiologic, or other clinical test performed to determine the presence, absence, or degree of a condition.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C77140</obo:NCIT_NHC0>
        <obo:NCIT_P106>Finding</obo:NCIT_P106>
        <obo:NCIT_P108>Clinical Test Result</obo:NCIT_P108>
        <obo:NCIT_P207>C0456984</obo:NCIT_P207>
        <obo:NCIT_P366>Clinical_Test_Result</obo:NCIT_P366>
        <oboInOwl:hasExactSynonym>Clinical Test Result</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Diagnostic Test Result</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Test Result</oboInOwl:hasExactSynonym>
        <rdfs:label>Clinical Test Result</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C78272 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C78272">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:IAO_0000115>An agent that exerts a physiologic effect on neurotransmission or on any anatomic entity that is part of the nervous system, including the central nervous system (CNS) and peripheral nervous system (PNS).</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Agent Affecting Nervous System</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C78275 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C78275">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:IAO_0000115>An agent that exerts an effect on the synthesis or function of blood, blood components or body fluids.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Agent Affecting Blood or Body Fluid</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C798 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C798">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C274"/>
        <obo:IAO_0000115>An agent that makes tumor cells more sensitive to radiation therapy.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Radiosensitizing Agent</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C860 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C860">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C552"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C616"/>
        <obo:IAO_0000115>The class of compound known as terpenes comprise of essential oils, flavours and fragrances. The extraction and synthesis of compounds such as these is the basis for the perfumery industry. They find a variety of uses in the food and pharmaceutical industry as flavour and odour improvers</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Terpene Compound</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C870 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C870">
        <obo:IAO_0000115>A synthetic derivative of glutamic acid (alpha-phthalimido-glutarimide) with teratogenic, immunomodulatory, anti-inflammatory and anti-angiogenic properties.  Thalidomide acts primarily by inhibiting both the production of tumor necrosis factor alpha (TNF-alpha) in stimulated peripheral monocytes and the activities of interleukins and interferons.  This agent also inhibits polymorphonuclear chemotaxis and monocyte phagocytosis.  In addition, thalidomide inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), thereby inhibiting angiogenesis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1909"/>
        <obo:NCIT_A7 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20450"/>
        <obo:NCIT_A7 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C20535"/>
        <obo:NCIT_NHC0>C870</obo:NCIT_NHC0>
        <obo:NCIT_P106>Organic Chemical</obo:NCIT_P106>
        <obo:NCIT_P106>Pharmacologic Substance</obo:NCIT_P106>
        <obo:NCIT_P107>Thalidomide</obo:NCIT_P107>
        <obo:NCIT_P108>Thalidomide</obo:NCIT_P108>
        <obo:NCIT_P207>C0039736</obo:NCIT_P207>
        <obo:NCIT_P210>50-35-1</obo:NCIT_P210>
        <obo:NCIT_P319>4Z8R6ORS6L</obo:NCIT_P319>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P322>FDA</obo:NCIT_P322>
        <obo:NCIT_P325>A drug that is used to treat multiple myeloma in patients who have just been diagnosed, and a painful skin disease related to leprosy. It is also being studied in the treatment of other types of cancer. Thalomid belongs to the family of drugs called angiogenesis inhibitors.</obo:NCIT_P325>
        <obo:NCIT_P350>C13H10N2O4</obo:NCIT_P350>
        <obo:NCIT_P366>Thalidomide</obo:NCIT_P366>
        <obo:NCIT_P368>CHEBI:9513</obo:NCIT_P368>
        <obo:NCIT_P375>Thalidomide</obo:NCIT_P375>
        <obo:NCIT_P399>42332</obo:NCIT_P399>
        <oboInOwl:hasExactSynonym>(+)-Thalidomide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>(-)-Thalidomide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>.alpha.-Phthalimidoglutarimide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>2, 6-Dioxo-3-phthalimidopiperidine</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>2,6-Dioxo-3-phthalimidopiperidine</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>3-Phthalimidoglutarimide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Alpha-Phthalimidoglutarimide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Contergan</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Distaval</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Kevadon</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>N-(2,6-Dioxo-3-piperidyl)phthalimide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>N-Phthaloylglutamimide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>N-Phthalylglutamic Acid Imide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>N-Phthalylglutamic acid imide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Neurosedyn</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Pantosediv</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Phthalimide, N-(2, 6-dioxo-3-piperidyl)-, (+)-</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Phthalimide, N-(2, 6-dioxo-3-piperidyl)-, (-)-</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Sedalis</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Sedoval K-17</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Softenon</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Synovir</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>THALIDOMIDE</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Talimol</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Thalidomide</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Thalomid</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>thalidomide</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C128784"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157712"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C173381"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C173383"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C176424"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C63923"/>
        <rdfs:label>Thalidomide</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C932 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C932">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1931"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C221"/>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Vinca Alkaloid Compound</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C93259 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C93259">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C163953"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1742"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1967"/>
        <obo:IAO_0000115>Any substance that inhibits vascular endothelial growth factor receptor, a family of tyrosine kinase receptors involved in the formation of blood vessels.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>VEGFR Tyrosine Kinase Inhibitor</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C933 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C933">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C67422"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C932"/>
        <obo:IAO_0000115>A natural alkaloid isolated from the plant Vinca rosea Linn. Vincristine binds irreversibly to microtubules and spindle proteins in S phase of the cell cycle and interferes with the formation of the mitotic spindle, thereby arresting tumor cells in metaphase. This agent also depolymerizes microtubules and may also interfere with amino acid, cyclic AMP, and glutathione metabolism; calmodulin-dependent Ca++ -transport ATPase activity; cellular respiration; and nucleic acid and lipid biosynthesis. (NCI04)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Vincristine</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C94728 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C94728">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C1557"/>
        <obo:IAO_0000115>Any fluoropyrimidine-based agent with potential antineoplastic activity. As an antimetabolite, a fluoropyrimidine interferes with pyrimidine utilization and incorporation into DNA and RNA.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Fluoropyrimidine</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C95124 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C95124">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C129825"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C93259"/>
        <obo:IAO_0000115>A synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. Lenvatinib blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Lenvatinib</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C95177 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C95177">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C96242"/>
        <obo:IAO_0000115>A stage term that applies to cervical cancer and indicates that the tumor invades beyond the uterus but not to the pelvic wall or to the lower third of vagina. There is no parametrial invasion.  The lesion is clinically visible and measures 4.0 cm or less in greatest dimension.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C95177</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIA1</obo:NCIT_P108>
        <obo:NCIT_P207>C2986966</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P375>Stage IIA1</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIA1</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIA1</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C95178 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C95178">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C96242"/>
        <obo:IAO_0000115>A stage term that applies to cervical cancer and indicates that the tumor invades beyond the uterus but not to the pelvic wall or to the lower third of vagina. There is no parametrial invasion.  The lesion is clinically visible and measures more than 4.0 cm in greatest dimension.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C95178</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIA2</obo:NCIT_P108>
        <obo:NCIT_P207>C2986967</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P375>Stage IIA2</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIA2</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIA2</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C95179 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C95179">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27982"/>
        <obo:IAO_0000115>A stage term that applies to uterine corpus cancer and indicates that the tumor is confined to the corpus uteri, or it invades the stromal connective tissue of the cervix but does not extend beyond the uterus, or it involves serosa and/or adnexa, vagina, or parametrial tissue. There is regional lymph node metastasis to the pelvic lymph nodes.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C95179</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIIC1</obo:NCIT_P108>
        <obo:NCIT_P207>C2986968</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P375>Stage IIIC1</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIIC1</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIIC1</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C95180 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C95180">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27982"/>
        <obo:IAO_0000115>A stage term that applies to uterine corpus cancer and indicates that the tumor is confined to the corpus uteri, or it invades stromal connective tissue of the cervix but does not extend beyond the uterus, or it involves serosa and/or adnexa, vagina, or parametrial tissue.  There is regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177555"/>
        <obo:NCIT_A32 rdf:resource="http://purl.obolibrary.org/obo/NCIT_C177556"/>
        <obo:NCIT_NHC0>C95180</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIIC2</obo:NCIT_P108>
        <obo:NCIT_P207>C2986969</obo:NCIT_P207>
        <obo:NCIT_P322>GDC</obo:NCIT_P322>
        <obo:NCIT_P375>Stage IIIC2</obo:NCIT_P375>
        <oboInOwl:hasExactSynonym>Stage IIIC2</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C177537"/>
        <rdfs:label>Stage IIIC2</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C9549 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C9549">
        <obo:IAO_0000115>A chemotherapy regimen consisting of cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C9549</obo:NCIT_NHC0>
        <obo:NCIT_P106>Therapeutic or Preventive Procedure</obo:NCIT_P106>
        <obo:NCIT_P107>CHOP Regimen</obo:NCIT_P107>
        <obo:NCIT_P108>CHOP Regimen</obo:NCIT_P108>
        <obo:NCIT_P207>C0055598</obo:NCIT_P207>
        <obo:NCIT_P322>CTRP</obo:NCIT_P322>
        <obo:NCIT_P325>An abbreviation for a chemotherapy combination that is used to treat non-Hodgkin lymphoma and is being studied in the treatment of other types of cancer. It includes the drugs cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone.</obo:NCIT_P325>
        <obo:NCIT_P366>Cyclophosphamide_Doxorubicin_Prednisone_Vincristine</obo:NCIT_P366>
        <obo:NCIT_P399>40931</obo:NCIT_P399>
        <obo:NCIT_P98>Source: NCCN Guidelines 2007 and PDQ</obo:NCIT_P98>
        <oboInOwl:hasExactSynonym>ACOP</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CAVP</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CHOP</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CHOP Regimen</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CHOP regimen</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>COPA</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>CTX/DOX/PRED/VCR</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone Regimen</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>Cyclophosphamide/Doxorubicin/Prednisone/Vincristine</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>VACP</oboInOwl:hasExactSynonym>
        <oboInOwl:hasExactSynonym>VCAP</oboInOwl:hasExactSynonym>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116977"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C116978"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C157711"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C160950"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C160952"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C165496"/>
        <oboInOwl:inSubset rdf:resource="http://purl.oboInOwllibrary.org/oboInOwl/NCIT_C176424"/>
        <rdfs:label>CHOP Regimen</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C96240 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C96240">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27976"/>
        <obo:IAO_0000115>A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: IB (T1b, N0, M0); IB1 (T1b1, N0, M0); IB2 (T1b2, N0, M0). (partially adapted from AJCC)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C96240</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IB Cervix</obo:NCIT_P108>
        <obo:NCIT_P207>C3272667</obo:NCIT_P207>
        <oboInOwl:hasExactSynonym>Stage IB Cervix</oboInOwl:hasExactSynonym>
        <rdfs:label>Stage IB Cervix</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C96241 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C96241">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C28054"/>
        <obo:IAO_0000115>A stage term referring to cervical cancer invading beyond uterus but not to pelvic wall or to lower third of vagina, without lymph node involvement or distant metastasis. Parametrial invasion may or may not be present.  It includes: IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0); IIB (T2b, N0, M0); T2: Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (partially adapted from AJCC)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C96241</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage II Cervix</obo:NCIT_P108>
        <obo:NCIT_P207>C3272668</obo:NCIT_P207>
        <oboInOwl:hasExactSynonym>Stage II Cervix</oboInOwl:hasExactSynonym>
        <rdfs:label>Stage II Cervix</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C96242 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C96242">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C27967"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C96241"/>
        <obo:IAO_0000115>A stage term referring to cervical cancer invading beyond uterus but not to pelvic wall or to lower third of vagina, without lymph node involvement or distant metastasis.  There is no parametrial invasion. It includes: IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0).  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (partially adapted from AJCC)</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <obo:NCIT_NHC0>C96242</obo:NCIT_NHC0>
        <obo:NCIT_P106>Clinical Attribute</obo:NCIT_P106>
        <obo:NCIT_P108>Stage IIA Cervix</obo:NCIT_P108>
        <obo:NCIT_P207>C3272669</obo:NCIT_P207>
        <oboInOwl:hasExactSynonym>Stage IIA Cervix</oboInOwl:hasExactSynonym>
        <rdfs:label>Stage IIA Cervix</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/NCIT_C98283 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/NCIT_C98283">
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C129825"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/NCIT_C155322"/>
        <obo:IAO_0000115>An orally available Raf kinase inhibitor with potential antineoplastic activity. Encorafenib specifically inhibits Raf kinase, a serine/threonine enzyme in the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-related kinase (ERK) signaling pathway. By inhibiting the activation of the RAF/MEK/ERK signaling pathway, the administration of LGX818 may result in a decrease in proliferation of tumor cells. The Raf mutation BRAF V600E is frequently upregulated in a variety of human tumors and results in the constitutive activation of the RAF/MEK/ERK signaling pathway that regulates cellular proliferation and survival.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/ncit.owl"/>
        <rdfs:label>Encorafenib</rdfs:label>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/OMIT_0026653 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/OMIT_0026653">
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/omit.owl"/>
        <rdfs:label>Cryopyrin-Associated Periodic Syndromes</rdfs:label>
    </owl:Class>
    


    <!-- http://www.ebi.ac.uk/efo/EFO_1001494 -->

    <owl:Class rdf:about="http://www.ebi.ac.uk/efo/EFO_1001494">
        <obo:IAO_0000115>Plaque psoriasis is the most common presentation of psoriasis. It presents as small to large, well demarcated, red, scaly and thickened areas of skin. It most likely to affect elbows, knees, and lower back but may arise on any part of the body.</obo:IAO_0000115>
        <obo:IAO_0000412 rdf:resource="http://www.ebi.ac.uk/efo/efo.owl"/>
        <oboInOwl:hasDbXref>ICD10:L40.0</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>MedDRA:10050576</oboInOwl:hasDbXref>
        <oboInOwl:hasDbXref>SNOMEDCT:200975007</oboInOwl:hasDbXref>
        <oboInOwl:hasExactSynonym>plaque psoriasis</oboInOwl:hasExactSynonym>
        <rdfs:label>psoriasis vulgaris</rdfs:label>
    </owl:Class>
</rdf:RDF>



<!-- Generated by the OWL API (version 4.5.25.2023-02-15T19:15:49Z) https://github.com/owlcs/owlapi -->

